<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.sc7ad4962346f485ea08e3ee593ade6c1Normal { text-align: center; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sc7ad4962346f485ea08e3ee593ade6c1HG4 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.sc7ad4962346f485ea08e3ee593ade6c1HG4C { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sc7ad4962346f485ea08e3ee593ade6c1Normal-000000 { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } p.sc7ad4962346f485ea08e3ee593ade6c1B { margin-left: 1.38in; text-indent: -1.38in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B - DRUGS AND SUBSTANCES CONTROL"><meta property="og:description" content="SDLRC Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL"><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1Normal"><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1HG4">CHAPTER </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B</span></a></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1Normal"><span class="sc7ad4962346f485ea08e3ee593ade6c1HG4C">DRUGS AND SUBSTANCES CONTROL</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1Normal-000000"><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont"> </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Definitions. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-2" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-2</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Drug defined. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-3" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-3</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Controlled drug or substance defined. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-3.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-3.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Controlled substance analogue. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-4" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-4</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Precursor defined. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-4.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-4.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Anabolic steroid defined. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-5" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-5</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-5" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-5</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont"> to 34-20B-9. Superseded.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-10" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-10</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Scheduled substances to be controlled--Nomenclature in schedules. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-11" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-11</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Criteria for inclusion of substance in Schedule I. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-12" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-12</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Specific substances included in Schedule I.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-13" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-13</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Opium derivatives and opiates included in Schedule I. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-14" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-14</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Hallucinogenic substances included in Schedule I. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-15" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-15</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Criteria for inclusion of substances in Schedule II. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-16" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-16</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Substances included in Schedule II.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-17" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-17</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Opiates included in Schedule II.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-18" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-18</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Criteria for inclusion of substances in Schedule III. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-19" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-19</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Stimulants specifically included in Schedule III. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-19.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-19.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Ephedrine defined. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-20" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-20</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Depressants specifically included in Schedule III. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-20.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-20.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Gamma hydroxyl butyrate defined. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-20.2" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-20.2</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Xylazine--Permissible uses.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-21" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-21</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Exception from Schedule III of stimulants and depressants used in medicinal preparations. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-22" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-22</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Specific substances included in Schedule III. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-23" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-23</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Narcotics specifically included in Schedule III. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-24" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-24</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Criteria for inclusion of substances in Schedule IV. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-25" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-25</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Substances included in Schedule IV.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-26" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-26</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Narcotic compounds specifically included in Schedule IV. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-27" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-27</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Recommendations for addition, deletion, or rescheduling of scheduled substances. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Substances not subject to control as precursors of precursors. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Definition of terms applicable to code imprinted drugs. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28.2" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28.2</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Code imprint required. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28.3" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28.3</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Manufacturers' and distributors' identifying listings. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28.4" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28.4</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Exemptions--Granting on appropriate showing--Inclusion in listings. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28.5" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28.5</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Contraband--Seizure and forfeiture. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28.6" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-28.6</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Dispensing or sale without code imprint--Misdemeanor. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-29" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-29</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Registration of prescribers, manufacturers, distributors, and dispensers of controlled drug or substance. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-30" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-30</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Exemptions from annual registration requirements. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-31" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-31</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-31" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-31</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">. Repealed by SL 2004, ch 232, § 2.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-32" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-32</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Waiver of registration requirement by regulation. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-33" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-33</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Registration of previously registered or licensed establishments. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-34" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-34</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Separate registration required for each place of business or practice. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-35" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-35</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Criteria for registration of manufacturers and distributors. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-36" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-36</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Authorized Schedule I and II substances to be specified in manufacturer's or distributor's registration. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-37" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-37</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Practitioners registered to dispense Schedule II, III, and IV substances. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-38" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-38</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-38" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-38</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">. Repealed by SL 1989, ch 293, § 5.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-39" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-39</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Inventories and records of controlled substances required of registrants. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-40" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-40</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Inspection of registrant's premises authorized. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-41" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-41</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Promulgation of rules by department--Fees. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-42" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-42</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Unauthorized manufacture or distribution by registrant prohibited--Civil fine--Knowing violation as felony. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-42.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-42.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-42.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-42.1</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">, 34-20B-42.2. Repealed by SL 1992, ch 245, §§ 7, 8.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-43" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-43</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Omission or removal of required symbol prohibited--Civil fine--Knowing violation as misdemeanor. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-44" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-44</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Failure to keep or furnish required record or report prohibited--Civil fine--Knowing violation as felony. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-45" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-45</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Civil fine for violation by manufacturer or distributor--Knowing violation as felony. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-46" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-46</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Intentional distribution of Schedule I or II substance without order form as felony. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-47" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-47</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Intentional use of unauthorized registration number as felony. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-48" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-48</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Intentional falsification or omission of material information as felony. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-49" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-49</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Criminal penalties in addition to civil and administrative penalties. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-50" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-50</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-50" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-50</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">. Repealed by SL 1997, ch 203, § 1.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-51" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-51</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Survival of right of action. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-52" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-52</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Civil action for recovery from unlawful distributor--Limitation of actions. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-53" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-53</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Minor's recovery payable to parent or conservator. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-54" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-54</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Cooperation by department with federal and state agencies. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-55" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-55</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Centralized statistical unit--Availability of information. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-56" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-56</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    State agencies to cooperate with department. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-57" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-57</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Exchange of information between governmental officials. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-58" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-58</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    County and municipal funds authorized. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-59" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-59</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Use of county and municipal funds to make illegal purchases. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-60" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-60</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Use of county and municipal funds to employ special agents. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-61" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-61</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Law enforcement and cooperation by Division of Criminal Investigation and state's attorneys. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-62" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-62</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Attorney general to enforce chapter. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-63" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-63</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Special powers of agents of Division of Criminal Investigation. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-64" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-64</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Drug control fund created--Administration by attorney general--Expenditures--Excess funds. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-65" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-65</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-65" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-65</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">, 34-20B-66. Repealed by SL 1978, ch 178, § 577.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-67" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-67</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Peace officers to cooperate with Division of Criminal Investigation. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-68" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-68</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Trial court jurisdiction to enjoin violations. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-69" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-69</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Jury trial of violations of injunction. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-70" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-70</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Property subject to forfeiture.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-70.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-70.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-70.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-70.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont"> to 34-20B-80. Repealed by SL 2016, ch 138, §§ 23 to 33.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-81" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-81</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Unlawful substances deemed contraband--Summary forfeiture. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-82" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-82</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Unauthorized Schedule I substances deemed contraband--Summary seizure and forfeiture. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-83" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-83</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Seizure and summary forfeiture of plant precursors of Schedule I and II substances--Failure to produce registration as authority. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-84" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-84</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-84" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-84</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont"> to 34-20B-89. Repealed by SL 2016, ch 138, §§ 34 to 39.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-90" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-90</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Burden of proof as to registration or order form. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-91" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-91</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Enforcement officers exempt from liability. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-92" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-92</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Judicial review of department's decisions--Findings of fact conclusive. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-93" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-93</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-93" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-93</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont"> to 34-20B-99. Repealed by SL 2016, ch 169, §§ 23 to 29.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-100" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-100</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Contracts with government agencies or private organizations. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-101" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-101</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-101" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-101</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">, 34-20B-102. Repealed by SL 2016, ch 169, §§ 30, 31.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-103" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-103</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-103" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-103</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">, 34-20B-104. Repealed by SL 1985, ch 278, § 54.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-105" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-105</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Residential alcohol and drug abuse treatment program authorized at Human Services Center. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-106" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-106</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-106" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-106</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont"> to 34-20B-109. Repealed by SL 1985, ch 278, § 54.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-110" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-110</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-110" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-110</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">. Repealed by SL 2016, ch 169, § 32.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-111" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-111</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-111" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-111</span></a><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">, 34-20B-112. Repealed by SL 1985, ch 278, § 55.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-113" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-113</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Severability of provisions and applications. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-114" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-114</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Citation of chapter. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-115" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-115</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Kratom--Facilitating under age use--Penalty. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-115.1" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-115.1</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Kratom--Prohibited products--Labeling required--Penalty. </span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-116" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-116</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    State directed opioid trust fund established--Source of funds--Purpose.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-117" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-117</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Delta-8 Tetrahydrocannabinol, THC-O Acetate, Hexahydrocannabinol--Under Age--Misdemeanor.</span></p><p dir="ltr" class="sc7ad4962346f485ea08e3ee593ade6c1B"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-118" rel="noopener"><span class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">34-20B-118</span></a><span xml:space="preserve" class="sc7ad4962346f485ea08e3ee593ade6c1DefaultParagraphFont">    Industrial hemp--Chemical modification or conversion--Sale or distribution--Penalty.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s2e6162b5f860474dbef8da7142bf5fa5Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2e6162b5f860474dbef8da7142bf5fa5SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2e6162b5f860474dbef8da7142bf5fa5CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2e6162b5f860474dbef8da7142bf5fa5Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2 { margin-left: 1.25in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } a.s2e6162b5f860474dbef8da7142bf5fa5000000 { text-decoration: none; } p.s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber3 { margin-left: 1.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1-000001 { margin-left: 0.75in; text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2e6162b5f860474dbef8da7142bf5fa5000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2e6162b5f860474dbef8da7142bf5fa5NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2e6162b5f860474dbef8da7142bf5fa5SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-1 - Definitions."><meta property="og:description" content="SDLRC Codified Law 34-20B-1 - Definitions."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-1"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-1" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5SENU">34-20B-1</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5SENU">. </span><span class="s2e6162b5f860474dbef8da7142bf5fa5CL">Definitions.</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5Statute"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">Terms as used in this chapter mean:</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(1)    "Administer," to deliver a controlled drug or substance to the ultimate user or human research subject by injection, inhalation, or ingestion, or by any other means;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(2)    "Agent," an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser and includes a common or contract carrier, public warehouseman, or employee thereof;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(3)    "Chemically derived cannabinoid," a chemical substance created by a chemical reaction that changes the molecular structure of any chemical substance derived from the cannabis plant. The term does not include:</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(a)    Cannabinoids produced by decarboxylation from a naturally occurring cannabinoid acid without the use of a chemical catalyst;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><a id="_pagenumber4" class="s2e6162b5f860474dbef8da7142bf5fa5000000" rel="noopener"></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(b)    Non-psychoactive cannabinoids; or</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(c)    Cannabinoids in a topical cream product;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(4)    "Control," to add, remove, or change the placement of a drug, substance, or immediate precursor under §§ </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-27" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">34-20B-27</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont"> and </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-28" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">34-20B-28</span></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(5)    "Controlled substance analogue," any of the following:</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(a)    A substance that differs in its chemical structure from a controlled substance listed in or added to Schedule I or II only by substituting one or more hydrogens with halogens, or by substituting one halogen with a different halogen;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(b)    A substance that is an alkyl homolog of a controlled substance listed in or added to Schedule I or II; or</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(c)    A substance intended for human consumption:</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber3"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(i)    The chemical structure of which is substantially similar to the chemical structure of a controlled substance in Schedule I or II; or</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber3"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(ii)    That has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to, or greater than, the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1-000001"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">The term, controlled substance analogue, does not include a controlled substance or any substance for which there is an approved new drug application;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(6)    "Counterfeit substance," a controlled drug or substance that, or the container or labeling of a controlled drug or substance that, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number, or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person or persons who manufactured, distributed, or dispensed the substance, and thereby falsely purports or is represented to be the product of, or to have been distributed by, the other manufacturer, distributor, or dispenser;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(7)    "Deliver" or "delivery," the actual, constructive, or attempted transfer of a controlled drug, substance, or marijuana, whether or not there exists an agency relationship;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(8)    "Department," the Department of Health created by chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=1-43" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">1-43</span></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(9)    "Dispense," to deliver a controlled drug or substance to the ultimate user or human research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering, packaging, labeling, or compounding necessary to prepare the substance for such delivery;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(10)    "Distribute," to deliver a controlled drug, substance, or marijuana;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(11)    "Hashish," the resin extracted from any part of any plant of the genus cannabis that contains a delta-9 tetrahydrocannabinol concentration of more than three-tenths of one percent on a dry weight basis;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(12)    "Imprisonment," imprisonment in a state correctional facility unless the penalty specifically provides for imprisonment in the county jail;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(13)    "Kratom," any part of the leaf of the plant Mitragyna speciosa;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(14)    "Kratom product," a food as defined in § </span><a href="https://sdlegislature.gov/Statutes?Statute=39-4-1" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">39-4-1</span></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, or dietary ingredient, containing kratom;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(15)    "Manufacture," the production, preparation, propagation, compounding, or processing of a controlled drug or substance, either directly or indirectly by extraction from substances of natural origin, or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis. A manufacturer does not include a practitioner who dispenses or compounds prescription orders for delivery to the ultimate consumer;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(16)    "Marijuana," all parts of any plant of the genus cannabis, whether growing or not; the seeds thereof; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant or its seeds. The term does not include fiber produced from the mature stalks of the plant, or oil or cake made from the seeds of the plant, </span><a id="_pagenumber5" class="s2e6162b5f860474dbef8da7142bf5fa5000000" rel="noopener"></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">or the resin when extracted from any part of the plant, or a drug product approved by the United States Food and Drug Administration. The term does not include the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than three-tenths of one percent on a dry weight basis;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(17)    "Narcotic drug," any of the following, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(a)    Opium, coca leaves, or opiates;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(b)    A compound, manufacture, salt, derivative, or preparation of opium, coca leaves, or opiates;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(c)    A substance, and any compound, manufacture, salt, derivative, or preparation thereof, that is chemically identical to any of the substances referred to in subsections (a) and (b) of this subdivision;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1-000001"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">The term, narcotic drug, does not include decocainized coca leaves or extracts of coca leaves, which extracts do not contain cocaine or ecgonine;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(18)    "Opiate" or "opioid," any controlled drug or substance having an addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(19)    "Opium poppy," the plant of the species papaver somniferum L., except the seeds thereof;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(20)    "Person," any corporation, association, limited liability company, partnership, or one or more individuals;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(21)    "Poppy straw," all parts, except the seeds, of the opium poppy, after mowing;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(22)    "Practitioner,":</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(a)    A physician licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-4" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-4</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, a physician assistant licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-4A" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-4A</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, a dentist licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-6A" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-6A</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, an optometrist licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-7" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-7</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, a podiatrist licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-8" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-8</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, a certified registered nurse anesthetist licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-9" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-9</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, a certified nurse practitioner or certified nurse midwife licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-9A" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-9A</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, a pharmacist licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-11" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-11</span></a><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">, or a veterinarian licensed pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes?Statute=36-12" rel="noopener"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">36-12</span></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(b)    A government employee acting within the scope of employment; and</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber2"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(c)    A person permitted by a certificate issued by the department to distribute, dispense, conduct research with respect to, or administer a substance controlled by this chapter;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(23)    "Prescription," an order of a practitioner for a controlled drug or substance;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(24)    "Production," the manufacture, planting, cultivation, growing, or harvesting of a controlled drug or substance;</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5StatuteNumber1"><a id="_pagenumber6" class="s2e6162b5f860474dbef8da7142bf5fa5000000" rel="noopener"></a><span class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont">(25)    "Ultimate user," a person who lawfully possesses a controlled drug or substance for personal use or for the use of a member of the person's household, or for administration to an animal owned by the person or by a member of the person's household.</span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5Normal"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5000002"> </span></p><p dir="ltr" class="s2e6162b5f860474dbef8da7142bf5fa5NoIndent"><span xml:space="preserve" class="s2e6162b5f860474dbef8da7142bf5fa5DefaultParagraphFont-000003">Source: </span><span class="s2e6162b5f860474dbef8da7142bf5fa5SCL">SL 1970, ch 229, § 6; SDCL Supp, § 39-17-44; SL 1972, ch 216, § 1; SL 1974, ch 266, § 1; SL 1975, ch 256; SL 1976, ch 158, § 42-9; SL 1981, ch 260, §§ 1, 2; SL 1981, ch 375, §§ 18, 19; SL 1984, ch 239, § 1; SL 1985, ch 185, § 2; SL 1986, ch 306, § 11; SL 1989, ch 21, § 158; SL 1989, ch 293, § 1; SL 1994, ch 351, § 61; SL 1995, ch 191, § 4; SL 2004, ch 229, § 1; SL 2013, ch 156, § 1, eff. Mar. 6, 2013; SL 2017, ch 155, § 1; SL 2017, ch 171, § 50; SL 2019, ch 148, § 1, eff. Feb. 19, 2019; SL 2020, ch 176, § 23, eff. Mar. 27, 2020; SL 2020, ch 169, § 4; SL 2023, ch 82, § 98; SL 2023, ch 119, § 1, eff. Feb. 9, 2023; SL 2024, ch 129, § 1; SL 2025, ch 138, § 1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056815Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056815SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056815CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056815Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056815DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056815Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056815000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056815SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056815SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056815Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-2"><span class="s2056815SENU">34-20B-2</span></a><span xml:space="preserve" class="s2056815SENU">. </span><span class="s2056815CL">Drug defined.</span></p><p dir="ltr" class="s2056815Normal-000000"><span class="s2056815DefaultParagraphFont">For the purposes of this chapter, unless the context otherwise requires, "drug" means:</span></p><p dir="ltr" class="s2056815Normal-000001"><span class="s2056815DefaultParagraphFont">(1)    Articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them, unless the department shall determine that any such article is inconsistent with the provisions of this chapter or are not appropriate to conditions which exist in this state, and by regulation specifically excludes any such article;</span></p><p dir="ltr" class="s2056815Normal-000001"><span class="s2056815DefaultParagraphFont">(2)    Articles intended for use, or used, in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals;</span></p><p dir="ltr" class="s2056815Normal-000001"><span class="s2056815DefaultParagraphFont">(3)    Articles (other than food) intended to affect, or affecting, the structure or any function of the body of man or other animals; and</span></p><p dir="ltr" class="s2056815Normal-000001"><span class="s2056815DefaultParagraphFont">(4)    Articles intended for use, or used, as a component of any articles specified in clauses (1), (2), or (3) of this section, but does not include mechanical devices or their components, parts, or accessories.</span></p><p dir="ltr" class="s2056815Normal"><span xml:space="preserve" class="s2056815000002"> </span></p><p dir="ltr" class="s2056815Normal"><span class="s2056815SCL">Source:</span><span xml:space="preserve" class="s2056815SCL-000003"> SL 1970, ch 229, § 6 (j); SDCL Supp, § 39-17-45.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056816Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056816SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056816CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056816Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056816DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056816000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056816SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056816SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056816Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-3"><span class="s2056816SENU">34-20B-3</span></a><span xml:space="preserve" class="s2056816SENU">. </span><span class="s2056816CL">Controlled drug or substance defined.</span></p><p dir="ltr" class="s2056816Normal-000000"><span xml:space="preserve" class="s2056816DefaultParagraphFont">For the purposes of this chapter, unless the context otherwise requires, "controlled drug or substance" means a drug, substance, or immediate precursor in Schedules I through IV of §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-11"><span class="s2056816DefaultParagraphFont">34-20B-11</span></a><span xml:space="preserve" class="s2056816DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2056816DefaultParagraphFont">34-20B-26</span></a><span class="s2056816DefaultParagraphFont">, inclusive.</span></p><p dir="ltr" class="s2056816Normal"><span xml:space="preserve" class="s2056816000001"> </span></p><p dir="ltr" class="s2056816Normal"><span class="s2056816SCL">Source:</span><span xml:space="preserve" class="s2056816SCL-000002"> SL 1970, ch 229, § 6 (e); SDL Supp, § 39-17-46; SL 1976, ch 158, § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=42-10"><span class="s2056816SCL-000002">42-10</span></a><span class="s2056816SCL-000002">.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056817Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056817SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056817CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056817Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056817DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056817000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056817SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056817SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056817Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-3.1"><span class="s2056817SENU">34-20B-3.1</span></a><span xml:space="preserve" class="s2056817SENU">. </span><span class="s2056817CL">Controlled substance analogue.</span></p><p dir="ltr" class="s2056817Normal-000000"><span class="s2056817DefaultParagraphFont">A controlled substance analogue shall be treated as a controlled substance in schedule I.</span></p><p dir="ltr" class="s2056817Normal"><span xml:space="preserve" class="s2056817000001"> </span></p><p dir="ltr" class="s2056817Normal"><span class="s2056817SCL">Source:</span><span xml:space="preserve" class="s2056817SCL-000002"> SL 2013, ch 156, § 2, eff. Mar. 6, 2013.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056818Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056818SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056818CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056818Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056818DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056818000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056818SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056818SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056818Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-4"><span class="s2056818SENU">34-20B-4</span></a><span xml:space="preserve" class="s2056818SENU">. </span><span class="s2056818CL">Precursor defined.</span></p><p dir="ltr" class="s2056818Normal-000000"><span class="s2056818DefaultParagraphFont">For the purposes of this chapter, unless the context otherwise requires, "precursor" or "immediate precursor" means a substance which the department has found to be and by regulation designates as being a principal compound commonly used or produced primarily for use, and which is an immediate chemical intermediary used or likely to be used, in the manufacture of a controlled drug or substance, the control of which is necessary to prevent, curtail, or limit such manufacture.</span></p><p dir="ltr" class="s2056818Normal"><span xml:space="preserve" class="s2056818000001"> </span></p><p dir="ltr" class="s2056818Normal"><span class="s2056818SCL">Source:</span><span xml:space="preserve" class="s2056818SCL-000002"> SL 1970, ch 229, § 6 (u); SDCL Supp, § 39-17-47.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056819Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056819SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056819CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056819Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056819DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056819Normal-000001 { margin-top: 0; margin-bottom: 0; margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-right: 0; } p.s2056819Normal-000002 { margin-top: 0; margin-bottom: 0; margin-left: 1.14in; text-indent: -0.44in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-right: 0; } span.s2056819000003 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056819Normal-000004 { margin-top: 0; margin-bottom: 0; text-indent: 0.25in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056819SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056819SCL-000005 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056819Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-4.1"><span class="s2056819SENU">34-20B-4.1</span></a><span xml:space="preserve" class="s2056819SENU">. </span><span class="s2056819CL">Anabolic steroid defined.</span></p><p dir="ltr" class="s2056819Normal-000000"><span class="s2056819DefaultParagraphFont">An anabolic steroid is any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestins, and corticosteroids, that promotes muscle growth and includes:</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(1)    Androstanediol:</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(a)    3²,17²-dihydroxy-5±-androstane;</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(b)    3±,17²-dihydroxy-5±-androstane;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(2)    Androstanedione (5±-androstan-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(3)    Androstenediol:</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(a)    1-androstenediol (3²,17²-dihydroxy-5±-androst-1-ene);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(b)    1-androstenediol (3±,17²-dihydroxy-5±-androst-1-ene);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(c)    4-androstenediol (3²,17²-dihydroxy-androst-4-ene);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(d)    5-androstenediol (3²,17²-dihydroxy-androst-5-ene);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(4)    Androstenedione:</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(a)    1-androstenedione ([5±]-androst-1-en-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(b)    4-androstenedione (androst-4-en-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(c)    5-androstenedione (androst-5-en-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(5)    Bolasterone (7±,17±-dimethyl-17²-hydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(6)    Boldenone (17²-hydroxyandrost-1,4,-diene-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(7)    Calusterone (7²,17±-dimethyl-17²-hydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(8)    Clostebol (4-chloro-17²-hydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(9)    Dehydrochloromethyltestosterone (4-chloro-17²-hydroxy-17±-methyl-androst-1,4-dien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(10)    ”1-dihydrotestosterone (a.k.a. "1-testosterone") (17²-hydroxy-5±-androst-1-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(11)    4-dihydrotestosterone (17²-hydroxy-androstan-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(12)    Drostanolone (17²-hydroxy-2±-methyl-5±-androstan-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(13)    Ethylestrenol (17±-ethyl-17²-hydroxyestr-4-ene);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(14)    Fluoxymesterone (9-fluoro-17±-methyl-11²,17²-dihydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(15)    Formebolone (2-formyl-17±-methyl-11±,17²-dihydroxyandrost-1,4-dien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(16)    Furazabol (17±-methyl-17²-hydroxyandrostano[2,3-c]- furazan);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(17)    13²-ethyl-17±-hydroxygon-4-en-3-one;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(18)    4-hydroxytestosterone (4,17²-dihydroxy-androst-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(19)    4-hydroxy-19-nortestosterone (4,17²-dihydroxy-estr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(20)    Mestanolone (17±-methyl-17²-hydroxy-5±-androstan-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(21)    Mesterolone (1±-methyl-17²-hydroxy-[5±]-androstan-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(22)    Methandienone (17±-methyl-17²-hydroxyandrost-1,4-dien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(23)    Methandriol (17±-methyl-3²,17²-dihydroxyandrost-5-ene);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(24)    Methenolone (1-methyl-17²-hydroxy-5±-androst-1-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(25)    17±-methyl-3²,17²-dihydroxy-5±-androstane;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(26)    17±-methyl-3±,17²-dihydroxy-5±-androstane;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(27)    17±-methyl-3²,17²-dihydroxyandrost-4-ene;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(28)    17±-methyl-4-hydroxynandrolone (17±-methyl-4-hydroxy-17²-hydroxyestr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(29)    Methyldienolone (17±-methyl-17²-hydroxyestra-4,9(10)-dien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(30)    Methyltrienolone (17±-methyl-17²-hydroxyestra-4,9-11-trien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(31)    Methyltestosterone (17±-methyl-17²-hydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(32)    Mibolerone (7±,17±-dimethyl-17²- hydroxyestr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(33)    17±-methyl-”1-dihydrotestosterone (17²-hydroxy-17±-methyl-5±-androst-1-en-3-one) (also known as 17-±-methyl-1-testosterone);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(34)    Nandrolone (17²-hydroxyestr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(35)    Norandrostenediol:</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(a)    19-nor-4-androstenediol (3²,17²-dihydroxyestr-4-ene);</span></p><p dir="ltr" class="s2056819Normal-000002"><span xml:space="preserve" class="s2056819000003"> </span></p></div><div><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(b)    19-nor-4-androstenediol (3±,17²-dihydroxyestr-4-ene);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(c)    19-nor-5-androstenediol (3²,17²-dihydroxyestr-5-ene);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(d)    19-nor-5-androstenediol (3±,17²-dihydroxyestr-5-ene);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(36)    Norandrostenedione:</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(a)    19-nor-4-androstenedione (estr-4-en-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000002"><span class="s2056819DefaultParagraphFont">(b)    19-nor-5-androstenedione (estr-5-en-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(37)    Norbolethone (13²,17±-diethyl-17²-hydroxygon-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(38)    Norclostebol (4-chloro-17²-hydroxyestr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(39)    Norethandrolone (17±-ethyl-17²-hydroxyestr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(40)    Normethandrolone (17±-methyl-17²-hydroxyestr-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(41)    Oxandrolone (17±-methyl-17²-hydroxy-2-oxa-[5±]-androstan-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(42)    Oxymesterone (17±-methyl-4,17²-dihydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(43)    Oxymetholone (17±-methyl-2-hydroxymethylene-17²-hydroxy-[5±]-androstan- 3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(44)    Stanozolol (17±-methyl-17²-hydroxy-[5±]-androst-2-eno[3,2-c]-pyrazole);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(45)    Stenbolone (17²-hydroxy-2-methyl-[5±]-androst-1-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(46)    Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(47)    Testosterone (17²-hydroxyandrost-4-en-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(48)    Tetrahydrogestrinone (13²,17±-diethyl-17²-hydroxygon-4,9,11-trien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(49)    Trenbolone (17²-hydroxyestr-4,9,11-trien-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(50)    Boldione (androsta-1,4-diene-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(51)    Desoxymethyltestosterone (17±-methyl-5±-androst-2-en-17±-ol) (also known as madol);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(52)    19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(53)    Prostanozol (17²-hydroxy-5±-androstano[3,2-c]pyrazole);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(54)    Methasterone (2±,17±-dimethyl-5±-androstan-17²-ol-3-one);</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(55)    5±-Androstan-3,6,17-trione;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(56)    6-bromo-androstan-3,17-dione;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(57)    6-bromo-androsta-1,4-diene-3,17-dione;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(58)    4-chloro-17±-methyl-androsta-1,4-diene-3,17²-diol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span xml:space="preserve" class="s2056819DefaultParagraphFont">(59)    4-chloro-17±-methyl-androst-4-ene-3²,17²-diol; </span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(60)    4-chloro-17±-methyl-17²-hydroxy-androst-4-en-3-one;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(61)    4-chloro-17±-methyl-17²-hydroxy-androst-4-ene-3,11-dione;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(62)    4-chloro-17±-methyl-androsta-1,4-diene-3,17²-diol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(63)    2±,17±-dimethyl-17²-hydroxy-5±-androstan-3-one;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(64)    2±,17±-dimethyl-17²-hydroxy-5²-androstan-3-one;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(65)    2±,3±-epithio-17±-methyl-5±-androstan-17²-ol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(66)    [3,2-c]-furazan-5±-androstan-17²-ol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(67)    3²-hydroxy-estra-4,9,11-trien-17-one;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(68)    17±-methyl-androst-2-ene-3,17²-diol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(69)    17±-methyl-androsta-1,4-diene-3,17²-diol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(70)    Estra-4,9,11-triene-3,17-dione;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(71)    18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(72)    6±-Methyl-androst-4-ene-3,17-dione;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(73)    17±-Methyl-androstan-3-hydroxyimine-17²-ol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(74)    17±-Methyl-5±-androstan-17²-ol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(75)    17²-Hydroxy-androstano[2,3-d]isoxazole;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(76)    17²-Hydroxy-androstano[3,2-c]isoxazole;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(77)    4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5±-androstan-17²-ol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(78)    [3,2-c]pyrazole-androst-4-en-17²-ol;</span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(79)    [3,2-c]pyrazole-5±-androstan-17²-ol; and</span></p><p dir="ltr" class="s2056819Normal-000001"><span xml:space="preserve" class="s2056819000003"> </span></p><p dir="ltr" class="s2056819Normal-000001"><span class="s2056819DefaultParagraphFont">(80)    Any salt, ester, or ether of a drug or substance described or listed in this section, if that salt, ester, or ether promotes muscle growth.</span></p><p dir="ltr" class="s2056819Normal-000004"><span class="s2056819DefaultParagraphFont">The term, anabolic steroid, as defined in this section, does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species. However, if any person prescribes, dispenses, or distributes such a steroid for human use, the person shall be considered to have prescribed, dispensed, or distributed an anabolic steroid within the meaning of this section.</span></p><p dir="ltr" class="s2056819Normal"><span xml:space="preserve" class="s2056819000003"> </span></p><p dir="ltr" class="s2056819Normal"><span class="s2056819SCL">Source:</span><span xml:space="preserve" class="s2056819SCL-000005"> SL 1990, ch 269, § 1; SL 1992, ch 245, § 4; SL 2006, ch 179, § 1, eff. Feb. 9, 2006; SL 2010, ch 174, § 1, eff. Feb. 24, 2010; SL 2013, ch 156, § 3, eff. Mar. 6, 2013; SL 2016, ch 175, § 1, eff. Feb. 18, 2016.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-5 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-5 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-5"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-5 to 34-20B-9. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Superseded.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056821Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056821SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056821CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056821Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056821DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056821000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056821SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056821SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056821Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-10"><span class="s2056821SENU">34-20B-10</span></a><span xml:space="preserve" class="s2056821SENU">. </span><span class="s2056821CL">Scheduled substances to be controlled--Nomenclature in schedules.</span></p><p dir="ltr" class="s2056821Normal-000000"><span xml:space="preserve" class="s2056821DefaultParagraphFont">All controlled drugs and substances listed in §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-11"><span class="s2056821DefaultParagraphFont">34-20B-11</span></a><span xml:space="preserve" class="s2056821DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2056821DefaultParagraphFont">34-20B-26</span></a><span class="s2056821DefaultParagraphFont">, inclusive, are hereby controlled. The schedules set forth in said sections include the controlled drugs and substances listed or to be listed, by whatever official name, common or usual name, or trade name designated.</span></p><p dir="ltr" class="s2056821Normal"><span xml:space="preserve" class="s2056821000001"> </span></p><p dir="ltr" class="s2056821Normal"><span class="s2056821SCL">Source:</span><span xml:space="preserve" class="s2056821SCL-000002"> SL 1970, ch 229, §§ 7, 8; SDCL Supp, § 39-17-53.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056822Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056822SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056822CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056822Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056822DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056822Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056822000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056822SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056822SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056822Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-11"><span class="s2056822SENU">34-20B-11</span></a><span xml:space="preserve" class="s2056822SENU">. </span><span class="s2056822CL">Criteria for inclusion of substance in Schedule I.</span></p><p dir="ltr" class="s2056822Normal-000000"><span class="s2056822DefaultParagraphFont">To be included within Schedule I, a substance shall have:</span></p><p dir="ltr" class="s2056822Normal-000001"><span class="s2056822DefaultParagraphFont">(1)    A high potential for abuse;</span></p><p dir="ltr" class="s2056822Normal-000001"><span class="s2056822DefaultParagraphFont">(2)    No accepted medical use in the United States; and</span></p><p dir="ltr" class="s2056822Normal-000001"><span class="s2056822DefaultParagraphFont">(3)    A lack of accepted safety for use under medical supervision.</span></p><p dir="ltr" class="s2056822Normal"><span xml:space="preserve" class="s2056822000002"> </span></p><p dir="ltr" class="s2056822Normal"><span class="s2056822SCL">Source:</span><span xml:space="preserve" class="s2056822SCL-000003"> SL 1970, ch 229, § 8 (a); SDCL Supp, § 39-17-54; SL 1976, ch 158, § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=42-11"><span class="s2056822SCL-000003">42-11</span></a><span class="s2056822SCL-000003">.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056823Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056823SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056823CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056823Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056823DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056823StatuteNumber1 { margin-left: 0.75in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2056823StatuteNumber1-000000 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2056823StatuteNumber1-000001 { margin-left: 0.75in; text-indent: -0.50in; text-align: left; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056823000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056823NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056823DefaultParagraphFont-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056823SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056823Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-12"><span class="s2056823SENU">34-20B-12</span></a><span xml:space="preserve" class="s2056823SENU">. </span><span class="s2056823CL">Specific substances included in Schedule I.</span></p><p dir="ltr" class="s2056823Statute"><span class="s2056823DefaultParagraphFont">Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(1)    Acetylmethadol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(2)    Allylprodine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(3)    Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(4)    Alphameprodine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(5)    Alphamethadol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(6)    Benzethidine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(7)    Betacetylmethadol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(8)    Betameprodine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(9)    Betamethadol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(10)    Betaprodine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(11)    Clonitazene;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(12)    Dextromoramide;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(13)    Diampromide;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(14)    Diethyliambutene;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(15)    Dimenoxadol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(16)    Dimepheptanol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(17)    Dimethyliambutene;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(18)    Dioxaphetyl butyrate;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(19)    Dipipanone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(20)    Ethylmethylthiambutene;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(21)    Etonitazene;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(22)    Etoxeridine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(23)    Fenethylline;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(24)    Furethidine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(25)    Hydroxypethidine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(26)    Ketobemidone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(27)    Levomoramide;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(28)    Levophenacylmorphan;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(29)    Mecloqualone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(30)    Morpheridine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(31)    Noracymethadol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(32)    Norlevorphanol;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(33)    Normethadone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(34)    Norpipanone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(35)    Phenadoxone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(36)    Phenampromide;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(37)    Phenomorphan;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(38)    Phenoperidine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(39)    Piritramide;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(40)    Proheptazine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(41)    Properidine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(42)    Racemoramide;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(43)    Trimeperidine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(44)    Methaqualone;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(45)    N-benzylpiperazine;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(46)    4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18;</span></p><p dir="ltr" class="s2056823StatuteNumber1"><span class="s2056823DefaultParagraphFont">(47)    N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene;</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(48)    2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(49)    2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene, etazene);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(50)    N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(51)    N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(52)    N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(53)    2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000000"><span class="s2056823DefaultParagraphFont">(54)    N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000001"><span lang="es-ES" class="s2056823DefaultParagraphFont">(55)    7-[(10,11-dihydro-5 H -dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) (amineptine);</span></p><p dir="ltr" class="s2056823StatuteNumber1-000001"><span lang="es-ES" class="s2056823DefaultParagraphFont">(56)    N -phenyl- N2 -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) (mesocarb); and</span></p><p dir="ltr" class="s2056823StatuteNumber1-000001"><span class="s2056823DefaultParagraphFont">(57)    N -methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine).</span></p><p dir="ltr" class="s2056823Normal"><span xml:space="preserve" class="s2056823000002"> </span></p><p dir="ltr" class="s2056823NoIndent"><span xml:space="preserve" class="s2056823DefaultParagraphFont-000003">Source: </span><span class="s2056823SCL">SL 1970, ch 229, § 8 (a) (1); SDCL Supp, § 39-17-55; SL 1977, ch 315, § 1; SL 1985, ch 278, § 50; SL 1994, ch 278, § 1; SL 2003, ch 183, § 1; SL 2018, ch 203, § 1, eff. Feb. 8, 2018; SL 2021, ch 144, § 1, eff. Feb. 17, 2021; SL 2022, ch 109, § 1, eff. Feb. 9, 2022; SL 2024, ch 130, § 1, eff. Feb. 14, 2024.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.sbc0cfb7929634ae5a9c4ddb6bd44a513Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sbc0cfb7929634ae5a9c4ddb6bd44a513SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sbc0cfb7929634ae5a9c4ddb6bd44a513CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.sbc0cfb7929634ae5a9c4ddb6bd44a513Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } a.sbc0cfb7929634ae5a9c4ddb6bd44a513000000 { text-decoration: none; } p.sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber2 { margin-left: 1.25in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.sbc0cfb7929634ae5a9c4ddb6bd44a513Statute-000001 { text-indent: -0.05in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sbc0cfb7929634ae5a9c4ddb6bd44a513000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sbc0cfb7929634ae5a9c4ddb6bd44a513NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sbc0cfb7929634ae5a9c4ddb6bd44a513SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-13 - Opium derivatives and opiates included in Schedule I."><meta property="og:description" content="SDLRC Codified Law 34-20B-13 - Opium derivatives and opiates included in Schedule I."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-13"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-13" rel="noopener"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513SENU">34-20B-13</span></a><span xml:space="preserve" class="sbc0cfb7929634ae5a9c4ddb6bd44a513SENU">. </span><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513CL">Opium derivatives and opiates included in Schedule I.</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513Statute"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">Any of the following opium derivatives and opiates, their salts, isomers, esters, ethers, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of the salts, isomers, esters, ethers, and salts of isomers, esters, and ethers is possible within the specific chemical designation:</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(1)    Acetylcodone;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(2)    Benzylmorphine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(3)    Codeine methylbromide;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(4)    Codeine-N-Oxide;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(5)    Desomorphine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(6)    Drotebanol;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(7)    Heroin;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(8)    Hydromorphinol;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(9)    Methyldesorphine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(10)    Methylhydromorphine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(11)    Morphine methylbromide;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(12)    Morphine methylsulfonate;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(13)    Morphine-N-Oxide;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(14)    Myrophine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(15)    Nicocodeine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(16)    Nicomorphine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(17)    Normorphine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(18)    Thebacon;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(19)    3-Methylfentanyl;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><a id="_pagenumber2" class="sbc0cfb7929634ae5a9c4ddb6bd44a513000000" rel="noopener"></a><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(20)    Fentanyl analogs. Any substituted derivatives of fentanyl unless specifically excepted, listed in another schedule, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, that is structurally related to fentanyl by modification in any one or more of the following ways:</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber2"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(a)    By replacement of the phenyl portion of the phenethyl group by any monocycle whether or not further substituted in or on the monocycle;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber2"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(b)    By substitution in or on or replacement of the phenethyl group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro groups;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber2"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(c)    By substitution in or on the piperadine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino, phenyl, substituted phenyl, or nitro groups;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber2"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(d)    By replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; or</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber2"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(e)    By the replacement of the N-propionyl group by another acyl group.</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513Statute-000001"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">Some trade and other names: N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide (furanyl fentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryl fentanyl, acryloylfentanyl); N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (ortho-fluorofentanyl or 2-fluorofentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide (tetrahydrofuranyl fentanyl); 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (methoxyacetyl fentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide (cyclopropyl fentanyl), N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide (valeryl fentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide (butyrl fentanyl); N-[1-(2-hydroxy-2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide (Beta-Hydroxythiofentanyl); N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide (para-fluorobutyryl fentanyl); N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide (para-methoxybutyryl fentanyl); N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-chloroisobutyryl fentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl fentanyl); N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide (cyclopentyl fentanyl); N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide (ocfentanil); N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (para-fluoroisobutyryl fentanyl); (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide (Crotonyl fentanyl);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><a id="_pagenumber3" class="sbc0cfb7929634ae5a9c4ddb6bd44a513000000" rel="noopener"></a><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(21)    1-Methyl-4-phenyl-4-propionoxypiperidine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(22)    1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(23)    3,4-dichloro-N[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(24)    1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(25)    3,4-dichloro-N-[(1dimethylamino)cyclohexylmethyl]benzamide (AH-7921);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(26)    2-(2,4-dichlorophenyl)-N-2-(dimethylamino)cyclohexyl)-N-methylacetamide (U-48800);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(27)    Trans-3,4-dichloro-N-[2-(diethylamino)cyclohexyl]-N-methyl-benzamide (U-49900);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(28)    N-[2-(dimethylamino)cyclohexyl]-N-methyl-1,3-benzodioxole-5-carboxamide (Methylenedioxy-U-47700);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(29)    3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-isopropylbenzamide (Isopropyl-U-47700);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(30)    1-(1,2-Diphenylethyl)piperidine (Diphenidine);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(31)    N-Ethyl-1,2-diphenylethylamine (Ephenidine);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(32)    1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one (Brorphine);</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(33)    1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) (Zipeprol); and</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513StatuteNumber1"><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont">(34)    2-Methyl AP-237 (1Methyl-4(3Phenylprop-2-en-1-yl)Piperizin-1-yl)Butan-1-one).</span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513Normal"><span xml:space="preserve" class="sbc0cfb7929634ae5a9c4ddb6bd44a513000002"> </span></p><p dir="ltr" class="sbc0cfb7929634ae5a9c4ddb6bd44a513NoIndent"><span xml:space="preserve" class="sbc0cfb7929634ae5a9c4ddb6bd44a513DefaultParagraphFont-000003">Source: </span><span class="sbc0cfb7929634ae5a9c4ddb6bd44a513SCL">SL 1970, ch 229, § 8(a)(1); SDCL Supp, § 39-17-56; SL 1977, ch 315, § 2; SL 1981, ch 261, § 4; SL 1987, ch 255, § 1; SL 1988, ch 282, § 1; SL 2016, ch 175, § 2, eff. Feb. 18, 2016; SL 2017, ch 156, § 1, eff. Feb. 3, 2017; SL 2018, ch 203, § 2, eff. Feb. 8, 2018; SL 2019, ch 148, § 2, eff. Feb. 19, 2019; SL 2020, ch 144, § 1, eff. Mar. 9, 2020; SL 2021, ch 144, § 2, eff. Feb. 17, 2021; SL 2024, ch 130, § 2, eff. Feb. 14, 2024; SL 2025, ch 139, § 1, eff. Feb. 18, 2025.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s6ed24474973d4c0693f479b4af6cd23bNormal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s6ed24474973d4c0693f479b4af6cd23bSENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s6ed24474973d4c0693f479b4af6cd23bCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s6ed24474973d4c0693f479b4af6cd23bStatute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1 { margin-left: 0.75in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2 { margin-left: 1.25in; text-indent: -0.44in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000000 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001 { margin-left: 1.25in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000002 { margin-left: 0.75in; text-indent: -0.44in; text-align: justify; background: #FFFFFF; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s6ed24474973d4c0693f479b4af6cd23b000003 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s6ed24474973d4c0693f479b4af6cd23bNoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont-000004 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s6ed24474973d4c0693f479b4af6cd23bSCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-14 - Hallucinogenic substances included in Schedule I."><meta property="og:description" content="SDLRC Codified Law 34-20B-14 - Hallucinogenic substances included in Schedule I."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-14"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bNormal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-14" rel="noopener"><span class="s6ed24474973d4c0693f479b4af6cd23bSENU">34-20B-14</span></a><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bSENU">. </span><span class="s6ed24474973d4c0693f479b4af6cd23bCL">Hallucinogenic substances included in Schedule I.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatute"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">Any material, compound, mixture, or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, is included in Schedule I, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(1)    Bufotenine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(2)    Diethyltryptamine (DET);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(3)    Dimethyltryptamine (DMT);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(4)    5-methoxy-N, N-Dimethyltryptamine (5-MeO-DMT);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(5)    5-methoxy-3, 4-methylenedioxy amphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(6)    4-bromo-2, 5-dimethoxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(7)    4-methoxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(8)    4-methoxymethamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(9)    4-methyl-2, 5-dimethoxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(10)    Hashish and hash oil;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(11)    Ibogaine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(12)    Lysergic acid diethylamide;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(13)    Mescaline;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(14)    N-ethyl-3-piperidyl benzilate;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(15)    N-methyl-3-piperidyl benzilate;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(16)    1-(-(2-thienyl)cyclohexyl) piperidine (TCP);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(17)    Peyote, except that when used as a sacramental in services of the Native American church in a natural state which is unaltered except for drying or curing and cutting or slicing, it is hereby excepted;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(18)    Psilocybin;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(19)    Psilocyn;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(20)    Tetrahydrocannabinol, except that which occurs in industrial hemp as defined in § </span><a href="https://sdlegislature.gov/Statutes?Statute=38-35-1" rel="noopener"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">38-35-1</span></a><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">; in a drug product approved by the United States Food and Drug Administration; or marijuana in its natural and unaltered state; including any compound, except nabilone or compounds listed under a different schedule, structurally derived from 6,6 dimethyl-benzo[c]chromene by substitution at the 3-position with either alkyl (C3 to C8), methyl cycloalkyl, or adamantyl groups, whether or not the compound is further modified in any of the following ways:</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(a)    By partial to complete saturation of the C-ring; or</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(b)    By substitution at the 1-position with a hydroxyl or methoxy group; or</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(c)    By substitution at the 9-position with a hydroxyl, methyl, or methylhydoxyl group; or</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(d)    By modification of the possible 3-alkyl group with a 1,1 dimethyl moiety, a 1,1 cyclic moiety, an internal methylene group, an internal acetylene group, or a terminal halide, cyano, azido, or dimethylcarboxamido group.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000000"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade and other names: JWH-051; JWH-057; JWH-133; JWH-359; HHC; AM-087; AM-411; AM-855, AM-905; AM-906; AM-2389; HU-210; HU-211; HU-243; HU-336;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(21)    3, 4, 5-trimethoxy amphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(22)    3, 4-methylenedioxy amphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(23)    3-methoxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(24)    2, 5-dimethoxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(25)    2-methoxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(26)    2-methoxymethamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(27)    3-methoxymethamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(28)    Phencyclidine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(29)    3, 4-methylenedioxymethamphetamine (MDMA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(30)    3, 4-methylenedioxy-N-ethylamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(31)    N-hydroxy-3, 4-methylenedioxyamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(32)    4-methylaminorex (also known as 2-Amino-4-methyl/x-5-phenyl-2-oxazoline);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(33)    2,5 Dimethoxy-4-ethylamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(34)    N,N-Dimethylamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(35)    1-(1-(2-thienyl)cyclohexyl)pyrrolidine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(36)    Aminorex;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(37)    4,42 -Dimethylaminorex (4,42 -DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(38)    Cathinone and other variations, defined as any compound, material, mixture, preparation or other product unless listed in another schedule or an approved FDA drug, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways:</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(a)    By substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substitutents;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(b)    By substitution at the 3-position with an acyclic alkyl substituent; or</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(c)    By substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups or by inclusion of the 2-amino nitrogen atom in a cyclic structure.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000000"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: methcathinone, 4-methyl-N-methylcathinone (mephedrone); 3,4-methylenedioxy-N-methylcathinone (methylone); 3,4-methylenedioxypyrovalerone (MDPV); Naphthylpyrovalerone (naphyrone); 4-flouromethcathinone (flephedrone); 4-methoxymethcathinone (methedrone; Bk-PMMA); Ethcathinone (N-Ethylcathinone); 3,4-methylenedioxyethcathinone (ethylone); Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (butylone); N,N-dimethylcathinone (metamfepramone); Alpha-pyrrolidinopropiophenone (alpha-PPP); 4-methoxy-alpha-pyrrolidinopropiophenone (MOPPP); 3,4-methylenedioxyalphapyrrolidinopropiophenone (MDPPP); Alpha-pyrrolidinovalerophenone (alpha-PVP); 3-fluoromethcathinone; 4-Methyl-alpha-pyrrolidinobutiophenone (MPBP); Methyl-±-pyrrolindinopropiophenone (MPPP); Methyl-±-pyrrolidino-hexanophenone (MPHP); Buphedrone; Methyl-N-ethylcathinone; Pentedrone; Dimethylmethcathinone (DMMC); Dimethylethcathinone (DMEC); Methylenedioxymethcathinone (MDMC); Pentylone; Ethylethcathinone; Ethylmethcathinone; Fluoroethcathinone; methyl-alpha-pyrrolidinobutiophenone (MPBP); Methylecathinone (MEC); Methylenedioxy-alpha-pyrrolidinobutiophenone (MDPBP); Methoxymethcathinone (MOMC); Methylbuphedrone (MBP); Benzedrone (4-MBC); Dibutylone (DMBDB); Dimethylone (MDDMA); Diethylcathinone; Eutylone (EBDB); N-ethyl-N-Methylcathinone; N-ethylbuphedrone, 1-(1,3-benzodioxol-5-yl)2-(ethylamino)pentan-1-one (N-Ethylpentylone); 4'-Methyl-alpha-pyrrolidinopropiophenone (4-MEPPP, MPPP or M±PPP); alpha-Pyrrolidinobutiophenone (±-PBP); 1-(1,3-benzodioxol-5-yl)-2-(tert-butylamino)propan-1-one (Tertylone); 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)hexan-1-one (N-ethyl Hexylone); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pntan-1-one (Pentylone); N-ethylhexedrone (± ethylaminohexanophenone); alpha-pyrrolidinohexanophenone (±-PHP); 4-methyl-alpha-ethylaminopentiophenone (4-MEAP); 42 -methyl-alpha-pyrrolidinohexiophenone (MPHP); alpha-pyrrolidinoheptaphenone (PV8); 42 -chloro-alpha-pyrrolidinovalerophenone (4-chloro-±-PVP); Alpha-PIHP (4-methyl-1-phenyl-2-(pyrrolindin-1-yl)pentan-1-one;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(39)    2,5-Dimethoxy-4-ethylamphetamine (DOET);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(40)    Alpha-ethyltryptamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(41)    4-Bromo-2,5-dimethoxy phenethylamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(42)    2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(43)    1-(3-trifluoromethylphenyl) piperazine (TFMPP);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(44)    Alpha-methyltryptamine (AMT);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(45)    5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(46)    5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(47)    Synthetic cannabinoids. Any material, compound, mixture, or preparation that is not listed as a controlled substance in another schedule, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, modifications of the indole ring by nitrogen heterocyclic analog substitution or nitrogen heterocyclic analog substitution of the phenyl, benzyl, naphthyl, adamantly, cyclopropyl, cumyl, or propionaldehyde structure, and salts of isomers, homologues, and modifications, unless specifically excepted, whenever the existence of these salts, isomers, homologues, modifications, and salts of isomers, homologues, and modifications is possible within the specific chemical designation:</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(a)    Naphthoylindoles. Any compound containing a 2-(1- naphthoyl)indole or 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinhyl)methyl, 2-(4-morpholinyl)ethyl, cyanoalky, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: JWH-015; 1-pentyl-3-(1-naphthoyl)indole (JWH-018); 1-hexyl-3-(1-naphthoyl)indole (JWH-019); 1-butyl-3-(1-naphthoyl)indole (JWH-073); 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081); 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122); 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200); JWH-210; JWH-398; 1-pentyl-3-(1-naphthoyl)indole (AM-678); 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201); WIN 55-212; JWH-004; JWH-007; JWH-009; JWH-011; JWH-016; JWH-020; JWH-022; JWH-046; JWH-047; JWH-048; JWH-049; JWH-050; JWH-070; JWH-071; JWH-072; JWH-076; JWH-079; JWH-080; JWH-082; JWH-094; JWH-096; JWH-098; JWH-116; JWH-120; JWH-148; JWH-149; JWH-164; JWH-166; JWH-180; JWH-181; JWH-182; JWH-189; JWH-193; JWH-198; JWH-211; JWH-212; JWH-213; JWH-234; JWH-235; JWH-236; JWH-239; JWH-240; JWH-241; JWH-258; JWH-262; JWH-386; JWH-387; JWH-394; JWH-395; JWH-397; JWH-399; JWH-400; JWH-412; JWH-413; JWH-414; JWH-415; JWH-424; AM-678; AM-1220; AM-1221; AM-1235; AM-2232, THJ-2201;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(b)    Naphthylmethylindoles. Any compound containing a 1H-indol-2-yl-(1-naphthyl)methane or 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, cyanoalky, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: JWH-175; JWH-184; JWH-185; JWH-192; JWH-194; JWH-195; JWH-196; JWH-197; JWH-199;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(c)    Phenylacetylindoles. Any compound containing a 2-phenylacetylindole or 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, cyanoalky, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: 1-cyc lohexylethyl-3-(2-methoxyphenylacetyl)indole (SR-18); 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole (RCS-8); 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250); 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203); JWH-167; JWH-201; JWH-202; JWH-204; JWH-205; JWH-206; JWH-207; JWH-208; JWH-209; JWH-237; JWH-248; JWH-249; JWH-251; JWH-253; JWH-302; JWH-303; JWH-304; JWH-305; JWH-306; JWH-311; JWH-312; JWH-313; JWH-314; JWH-315; JWH-316; Cannabipiperidiethanone;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(d)    Benzoylindoles. Any compound containing a 2-(benzoyl)indole or 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, cyanoalky, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM-694); 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19); Pravadoline (WIN 48,098); 1-pentyl-3-[(4-methoxy)-benzoyl]indole (RCS-4); AM-630; AM-661; AM-2233; AM-1241;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(e)    Naphthoylpyrroles. Any compound containing a 2-(1-naphthoyl)pyrrole or 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, cyanoalky, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: JWH-307; JWH-030; JWH-031; JWH-145; JWH-146; JWH-147; JWH-150; JWH-156; JWH-242; JWH-243; JWH-244; JWH-245; JWH-246; JWH-292; JWH-293; JWH-308; JWH-309; JWH-346; JWH-348; JWH-363; JWH-364; JWH-365; JWH-367; JWH-368; JWH-369; JWH-370; JWH-371; JWH-373; JWH-392;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(f)    Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, cyanoalky, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not further substituted on the indene ring to any extent and whether or not substituted on the naphthyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: JWH-171; JWH-176; JWH-220;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(g)    Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group, whether or not substituted on the cyclohexyl ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade or other names: 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47, 497 and homologues, which includes C8); cannabicyclohexanol; CP-55,490; CP-55,940; CP-56,667;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(h)    (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol. Some trade or other names: HU-210;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(i)    2,3-Dihydro-5-methyl-3-(4-m orpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-napthalenyl. Some trade or other names: WIN 55, 2</span><a href="https://sdlegislature.gov/Statutes?Statute=12-2" rel="noopener"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">12-2</span></a><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(j)    Substituted Acetylindoles. Any compound containing a 2-acetyl indole or 3-acetyl indole structure substituted at the acetyl by replacement of the methyl group with a tetramethylcyclopropyl, adamantyl, benzyl, cumyl, or propionaldehyde substituent whether or not further substituted on the tetramethylcyclopropyl, adamantyl, benzyl, cumyl, or propionaldehyde substituent to any extent and whether or not further substituted at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group whether or not further substituted on the indole ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade and or names: (1-Pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144); (1-(5-fluoropentyl)indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (XLR-11); (1-(2-morpholin-4-ylethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone (A-796,260); 1-[(N-methylpiperidin-2-yl)methyl]-3-(adamant-1-oyl)indole (AM-1248); 1-Pentyl-3-(1-adamantoyl)indole (AB-001 and JWH-018 adamantyl analog); AM-679; (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (FUB-144);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(k)    Substituted Carboxamide Indole. Any compound containing a 2-carboxamide indole or 3-carboxamide indole structure substituted at the nitrogen of the carboxamide with a tetramethylcyclopropyl, naphthyl, adamantyl, cumyl, phenyl, or propionaldehyde substituent, whether or not further substituted on the tetramethylcyclopropyl, adamantyl, cumyl, naphthyl, phenyl, or propionaldehyde substituent to any extent and whether or not further substituted at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, (tetrahydropyran-4-yl)methyl, benzyl, or halobenzyl group whether or not further substituted on the indole ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade and other names: JWH-018 adamantyl carboxamide; STS-135; MN-18; 5-Fluoro-MN-18, 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (5F-CUMYL-P7AICA) ; N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-APINACA); methyl (2R)-2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate (5F-ADB); N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (AB-CHMINACA); 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (4-CN-CUMYL-BUTINACA); N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (ADB-CHMINACA or MAB-CHMINACA); methyl (2S)-2-[[1-[4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-FUBINACA); methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (MMB-CHMICA); methyl (2S)-2-[[1-[4-fluorophenyl)methyl]indazole-3-carbonyl]amino]-3-methylbutanoate (AMB-FUBINACA); Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (5F-AMB); methyl 2-(1-(5-fluoropentyl-1Hindole-3-carboxamido)-3,3-dimethylbutaoate (5F-MDMB-PICA); methyl (S)-3,3-dimethyl-2-[(1-(pent-4-enlindazole-3-carbonyl)amino]butanoate (MDMB-4en-PINACA); methyl 2-(1-(4-fluorobutyl)-1H-indazole-3carboxamido)-3,3-dimethylbutanoate (4F-MDMB-BUTINACA); Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-EDMB-PINACA); Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate S(5F-MDMB-PICA); N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (FUB-APINACA); 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (5F-CUMYL-PINACA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(l)    Substituted Carboxylic Acid Indole. Any compound containing a 1H-indole-2-carboxylic acid or 1H-indole-3-carboxylic acid substituted at the hydroxyl group of the carboxylic acid with a phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, quinolinyl, isquinolinyl, cumyl, or propionaldehyde substituent whether or not further substituted on the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, cumyl, quinolinyl, isquinolinyl, or propionaldehyde substituent to any extent and whether or not further substituted at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, benzyl, or halo benzyl group whether or not further substituted on the indole ring to any extent.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2-000001"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade and other names: Naphthalen-1-yl 1-(5-fluoropntyl)-1H-indole-3-carboxylate (NM2201);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(48)    6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine) (MDAI);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(49)    2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(50)    2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(51)    2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(52)    2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(53)    2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(54)    2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(55)    2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(56)    2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(57)    2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(58)    Substituted phenethylamine. Any compound, unless specifically exempt, listed as a controlled substance in another schedule or an approved FDA drug, structurally derived from phenylethan-2-amine by substitution on the phenyl ring in any of the following ways: by substitution with a fused methylenedioxy, fused furan, or fused tetrahydrofuran ring system; by substitution with two alkoxy groups; by substitution with one alkoxy and either one fused furan, tetrahydrofuran, or tetrahydropyran ring system; by substitution with two fused ring systems from any combination of the furan, tetrahydrofuran, or tetrahydropyran ring systems; whether or not the compound is further modified in any of the following ways:</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(a)    By substitution on the phenyl ring by any halo, hydroxyl, alkyl, trifluoromethyl, alkoxy, or alkylthio groups;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(b)    By substitution on the 2-position by any alkyl groups; or</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber2"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(c)    By substitution on the 2-amino nitrogen atom with acetyl, alkyl, dialkyl, benzyl, methoxybenzyl, or hydroxybenzyl groups.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000000"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade and other names: 2-(2,5-dimethoxy-4-(methylthio)phenyl)ethanamine (2C-T or 4-methylthio-2,5-dimethoxyphenethylamine); 1-(2,5-dimethoxy-4-iodophenyl)-propan-2-amine (DOI or 2, 5-Dimethoxy-4-iodoamphetamine); 1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane (DOB or 2,5-Dimethoxy-4-bromoamphetamine); 1-(4-chloro-2,5-dimethoxy-phenyl)propan-2-amine (DOC or 2,5-Dimethoxy-4-chloroamphetamine); 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (2C-B-NBOMe; 25B-NBOMe or 2,5-Dimethoxy-4-bromo-N-(2-methoxybenzyl)phenethylamine); 2-4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (2C-I-NBOMe; 25I-NBOMe or 2,5-Dimethoxy-4-iodo-N-(2-methoxybenzyl)phenethylamine); N-(2-Methoxybenzyl)-2-(3,4,5-trimethoxypheny (Mescaline-NBOMe or 3,4,5-trimethoxy-(2-methoxybenzyl)phenethylamine); 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (2C-C-NBOMe; 25C-NBOMe or 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)phenethylamine); 2-(7-Bromo-5-methoxy-2,3-dihydro-1-benzofuran-4-yl)ethanamine (2CB-5-hemiFLY); 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1]benzofuran-4-yl)ethanamine (2C-B-FLY); 2-(10-Bromo-2,3,4,7,8,9-hexahydropyrano[2,3-g]chromen-5-yl)ethanamine (2C-B-butterFLY); -(2-Methoxybenzyl)-1-(8-bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b]difuran-4-yl)-2-aminoethane (2C-B-FLY-NBOMe); 1-(4-Bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine (bromo-benzodifuranyl-isopropylamine or bromo-dragonFLY); -(2-Hydroxybenzyl)-4-iodo-2,5-dimethoxyphenethylamine (2C-I-NBOH or 25I-NBOH); 5-(2-Aminoprpyl)benzofuran (5-APB); 6(2-Aminopropyl)benzofuran (6-APB); 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB); 6-(2-Aminopropyl)-2,3,-dihydrobenzofuran (6-APDB); para-methoxymethamphetamine (PMMA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(59)    Substituted tryptamines. Any compound, unless specifically exempt, listed as a controlled substance in another schedule or an approved FDA drug, structurally derived from 2-(1H-indol-3-yl)ethanamine by mono- or di-substitution of the amine nitrogen with alkyl or alkenyl groups or by inclusion of the amino nitrogen atom in a cyclic structure whether or not the compound is further substituted at the alpha-position with an alkyl group or whether or not further substituted on the indole ring to any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy groups.</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000000"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">        Some trade and other names: 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT); 4-acetoxy-N,N-dimethyltryptamine (4-AcO-DMT or O-Acetylpsilocin); 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET); 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DIPT); 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(60)    Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (CB-13);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(61)    N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide (AKB 48);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(62)    1-(4-Fluorophenyl)piperazine (pFPP);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(63)    1-(3-Chlorophenyl)piperazine (mCPP);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(64)    1-(4-Methoxyphenyl)piperazine (pMeOPP);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(65)    1,4-Dibenzylpiperazine (DBP);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(66)    Isopentedrone;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(67)    Fluoromethamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(68)    Fluoroamphetamine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(69)    Fluorococaine;</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(70)    1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(71)    1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5 Fluoro-PB-22);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(72)    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(73)    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5 Fluoro-AB-PINACA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(74)    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(75)    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide (ADB-PINACA (ADBICA));</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(76)    N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5 Fluoro-ADB-PINACA (5 Fluoro-ADBICA));</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(77)    N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (ADB-FUBINACA);</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(78)    N-(1-carbamoyl-2-methyl-propyl)-2-(5-fluoropentyl)-5-(4-fluorophenyl)pyrazole-3-carboxamide (5-Fluoro-3,5-AB-PFUPPYCA); and</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bStatuteNumber1-000002"><span class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont">(79)    2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (methoxetamine).</span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bNormal"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23b000003"> </span></p><p dir="ltr" class="s6ed24474973d4c0693f479b4af6cd23bNoIndent"><span xml:space="preserve" class="s6ed24474973d4c0693f479b4af6cd23bDefaultParagraphFont-000004">Source: </span><span class="s6ed24474973d4c0693f479b4af6cd23bSCL">SL 1970, ch 229, § 8(a)(1); SDCL Supp, § 39-17-57; SL 1973, ch 259; SL 1976, ch 158, §§ 42-12, 42-13; SL 1977, ch 315, § 3; SL 1979, ch 238, § 1; SL 1987, ch 255, § 2; SL 1988, ch 282, § 2; SL 1989, ch 293, § 2; SL 1990, ch 270, § 1; SL 1993, ch 247, § 1; SL 1994, ch 278, § 2; SL 2003, ch 183, § 2; SL 2004, ch 230, § 1; SL 2011, ch 160, § 1, eff. Feb. 24, 2011; SL 2012, ch 183, § 1, eff. Feb. 23, 2012; SL 2013, ch 156, § 4, eff. Mar. 6, 2013; SL 2014, ch 165, § 1, eff. Feb. 10, 2014; SL 2015, ch 180, § 1, eff. Feb. 18, 2015; SL 2019, ch 148, § 3, eff. Feb. 19, 2019; SL 2020, ch 176, § 24, eff. Mar. 27, 2020; SL 2021, ch 144, § 3, eff. Feb. 17, 2021; SL 2022, ch 109, § 2, eff. Feb. 9, 2022; SL 2023, ch 119, § 2, eff. Feb. 9, 2023; SL 2025, ch 139, § 2, eff. Feb. 18, 2025.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056826Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056826SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056826CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056826Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056826DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056826Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056826000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056826SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056826SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056826Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-15"><span class="s2056826SENU">34-20B-15</span></a><span xml:space="preserve" class="s2056826SENU">. </span><span class="s2056826CL">Criteria for inclusion of substances in Schedule II.</span></p><p dir="ltr" class="s2056826Normal-000000"><span class="s2056826DefaultParagraphFont">To be included within Schedule II, a substance shall have:</span></p><p dir="ltr" class="s2056826Normal-000001"><span class="s2056826DefaultParagraphFont">(1)    A high potential for abuse,</span></p><p dir="ltr" class="s2056826Normal-000001"><span class="s2056826DefaultParagraphFont">(2)    Currently accepted medical use in the United States, or currently accepted medical use with severe restrictions, and</span></p><p dir="ltr" class="s2056826Normal-000001"><span class="s2056826DefaultParagraphFont">(3)    Abuse which may lead to severe psychic or physical dependence.</span></p><p dir="ltr" class="s2056826Normal"><span xml:space="preserve" class="s2056826000002"> </span></p><p dir="ltr" class="s2056826Normal"><span class="s2056826SCL">Source:</span><span xml:space="preserve" class="s2056826SCL-000003"> SL 1970, ch 229, § 8 (b); SDCL Supp, § 39-17-58; SL 1976, ch 158, § 42-14.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s2084767Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084767SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2084767CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2084767Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084767DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2084767StatuteNumber1 { margin-left: 0.75in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2084767StatuteNumber2 { margin-left: 1.25in; text-indent: -0.44in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084767000000 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2084767NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084767DefaultParagraphFont-000001 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2084767SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-16 - Substances included in Schedule II."><meta property="og:description" content="SDLRC Codified Law 34-20B-16 - Substances included in Schedule II."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes?Statute=34-20B-16"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s2084767Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-16" rel="noopener"><span class="s2084767SENU">34-20B-16</span></a><span xml:space="preserve" class="s2084767SENU">. </span><span class="s2084767CL">Substances included in Schedule II.</span></p><p dir="ltr" class="s2084767Statute"><span class="s2084767DefaultParagraphFont">Any of the following substances, including their salts, isomers, and salts of isomers, is included in Schedule II except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span xml:space="preserve" class="s2084767DefaultParagraphFont">(1)    Opium (except when it meets the requirements of subdivision </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-23" rel="noopener"><span class="s2084767DefaultParagraphFont">34-20B-23</span></a><span xml:space="preserve" class="s2084767DefaultParagraphFont">(7) or </span><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-26" rel="noopener"><span class="s2084767DefaultParagraphFont">34-20B-26</span></a><span class="s2084767DefaultParagraphFont">(5)), coca leaves, and opiate;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(2)    Any salt, compound, derivative, or preparation of opium, coca leaves (including cocaine), or opiate, excluding apomorphine, dextrorphan, naloxone, naloxegol, naldemedine, nalbuphine, nalmefene, naltrexone, 6ß-naltrexol, and samidorphan;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(3)    Any salt, compound, derivative, or preparation thereof that is chemically equivalent or identical with any of the substances referred to in subdivisions (1) and (2), except that these substances may not include decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; and may not include the isoquinoline alkaloids of opium;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(4)    Opium poppy and poppy straw;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(5)    Amphetamine;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(6)    Methamphetamine;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(7)    Amobarbital;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(8)    Pentobarbital;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(9)    Secobarbital;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(10)    Methylphenidate;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(11)    Phenmetrazine;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(12)    Etorphine;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(13)    Diprenorphine;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(14)    Deleted by SL 2000, ch 170, § 1;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(15)    Nabilone;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(16)    Glutethimide;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(17)    Phencyclidine immediate precursors:</span></p><p dir="ltr" class="s2084767StatuteNumber2"><span class="s2084767DefaultParagraphFont">(a)    1-phenylcyclohexylamine;</span></p><p dir="ltr" class="s2084767StatuteNumber2"><span class="s2084767DefaultParagraphFont">(b)    1-piperidinocyclohexanecarbonitrile (PCC);</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(18)    Lisdexamfetamine, its salts, isomers, and salts of its isomers;</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(19)    Tapentadol; and</span></p><p dir="ltr" class="s2084767StatuteNumber1"><span class="s2084767DefaultParagraphFont">(20)    Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States Food and Drug Administration.</span></p><p dir="ltr" class="s2084767Normal"><span xml:space="preserve" class="s2084767000000"> </span></p><p dir="ltr" class="s2084767NoIndent"><span xml:space="preserve" class="s2084767DefaultParagraphFont-000001">Source: </span><span class="s2084767SCL">SL 1970, ch 229, § 8 (b) (1); SDCL Supp, § 39-17-59; SL 1977, ch 315, § 4; SL 1978, ch 249, § 1; SL 1981, ch 13, § 9; SL 1981, ch 261, § 1; SL 1985, ch 278, § 51; SL 1986, ch 284; SL 1987, ch 255, § 3; SL 1992, ch 245, § 1; SL 1993, ch 247, § 2; SL 2000, ch 170, § 1; SL 2008, ch 170, § 1, eff. Feb. 13, 2008; SL 2010, ch 174, § 2, eff. Feb. 24, 2010; SL 2012, ch 183, § 2, eff. Feb. 23, 2012; SL 2015, ch 180, § 2, eff. Feb. 18, 2015; SL 2016, ch 175, § 3, eff. Feb. 18, 2016; SL 2018, ch 203, § 3, eff. Feb. 8, 2018; SL 2021, ch 144, § 4, eff. Feb. 17, 2021; SL 2022, ch 109, § 3, eff. Feb. 9, 2022.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2083020Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2083020SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2083020CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2083020Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2083020DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2083020StatuteNumber1 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } a.s2083020000000 { text-decoration: none; } span.s2083020000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2083020DefaultParagraphFont-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2083020SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2083020Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-17"><span class="s2083020SENU">34-20B-17</span></a><span xml:space="preserve" class="s2083020SENU">. </span><span xml:space="preserve" class="s2083020CL">Opiates included in Schedule II. </span></p><p dir="ltr" class="s2083020Statute"><span class="s2083020DefaultParagraphFont">Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(1)    Alphaprodine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(2)    Anileridine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(3)    Bezitramide;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(4)    Diphenoxylate;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(5)    Fentanyl;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(6)    Isomethadone;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(7)    Levomethorphan;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(8)    Levorphanol;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(9)    Metazocine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(10)    Methadone;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(11)    Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(12)    Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><a id="_pagenumber4" class="s2083020000000"></a><span class="s2083020DefaultParagraphFont">(13)    Pethidine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(14)    Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(15)    Pethidine-intermediate, B, ethyl-4-phenylpiperidine-4-carboxylate;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(16)    Pethidine-intermediate, C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(17)    Phenazocine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(18)    Piminodine;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(19)    Racemethorphan;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(20)    Racemorphan;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(21)    Sufentanil;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(22)    Alfentanil;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(23)    Carfentanil;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(24)    Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadyl acetate or LAAM;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(25)    Remifentanil;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(26)    Oxymorphone;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(27)    Oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(28)    4-anilino-N-phenethylpiperidine (ANPP);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span xml:space="preserve" class="s2083020DefaultParagraphFont">(29)    Morphine, except when it meets subdivision </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-23"><span class="s2083020DefaultParagraphFont">34-20B-23</span></a><span class="s2083020DefaultParagraphFont">(8);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(30)    Hydrocodone (Dihydrocodeinone);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span xml:space="preserve" class="s2083020DefaultParagraphFont">(31)    Codeine, except when it meets subdivision </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-23"><span class="s2083020DefaultParagraphFont">34-20B-23</span></a><span xml:space="preserve" class="s2083020DefaultParagraphFont">(1), </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-23"><span class="s2083020DefaultParagraphFont">34-20B-23</span></a><span xml:space="preserve" class="s2083020DefaultParagraphFont">(2), or </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2083020DefaultParagraphFont">34-20B-26</span></a><span class="s2083020DefaultParagraphFont">(1);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span xml:space="preserve" class="s2083020DefaultParagraphFont">(32)    Dihydrocodeine, except when it meets subdivision </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-23"><span class="s2083020DefaultParagraphFont">34-20B-23</span></a><span xml:space="preserve" class="s2083020DefaultParagraphFont">(5) or </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2083020DefaultParagraphFont">34-20B-26</span></a><span class="s2083020DefaultParagraphFont">(2);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span xml:space="preserve" class="s2083020DefaultParagraphFont">(33)    Ethylmorphine, except when it meets subdivision </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-23"><span class="s2083020DefaultParagraphFont">34-20B-23</span></a><span xml:space="preserve" class="s2083020DefaultParagraphFont">(6) or </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2083020DefaultParagraphFont">34-20B-26</span></a><span class="s2083020DefaultParagraphFont">(3);</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(34)    Oxycodone;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(35)    Hydromorphone;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(36)    Thiafentanil;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(37)    Noroxymorphone;</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(38)    N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl); and</span></p><p dir="ltr" class="s2083020StatuteNumber1"><span class="s2083020DefaultParagraphFont">(39)    Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate).</span></p><p dir="ltr" class="s2083020Normal"><span xml:space="preserve" class="s2083020000001"> </span></p><p dir="ltr" class="s2083020Normal"><span xml:space="preserve" class="s2083020DefaultParagraphFont-000002">Source: </span><span class="s2083020SCL">SL 1970, ch 229, § 8 (b) (1); SDCL Supp, § 39-17-60; SL 1985, ch 278, § 52; SL 1987, ch 255, § 4; SL 1989, ch 293, § 3; SL 1994, ch 278, § 3; SL 2002, ch 167, § 1; SL 2007, ch 194, § 1, eff. Feb. 1, 2007; SL 2008, ch 170, § 2, eff. Feb. 13, 2008; SL 2011, ch 160, § 2, eff. Feb. 24, 2011; SL 2015, ch 180, § 3, eff. Feb. 18, 2015; SL 2017, ch 156, § 2, eff. Feb. 3, 2017; SL 2020, ch 144, § 2, eff. Mar. 9, 2020; SL 2021, ch 144, § 5, eff. Feb. 17, 2021.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056829Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056829SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056829CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056829Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056829DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056829Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056829000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056829SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056829SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056829Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-18"><span class="s2056829SENU">34-20B-18</span></a><span xml:space="preserve" class="s2056829SENU">. </span><span class="s2056829CL">Criteria for inclusion of substances in Schedule III.</span></p><p dir="ltr" class="s2056829Normal-000000"><span class="s2056829DefaultParagraphFont">To be included within Schedule III, a substance shall have:</span></p><p dir="ltr" class="s2056829Normal-000001"><span class="s2056829DefaultParagraphFont">(1)    A potential for abuse less than the substances listed in Schedules I and II;</span></p><p dir="ltr" class="s2056829Normal-000001"><span class="s2056829DefaultParagraphFont">(2)    Well documented and approved medical use in the United States; and</span></p><p dir="ltr" class="s2056829Normal-000001"><span class="s2056829DefaultParagraphFont">(3)    Abuse which may lead to moderate or low physical dependence or high psychological dependence.</span></p><p dir="ltr" class="s2056829Normal"><span xml:space="preserve" class="s2056829000002"> </span></p><p dir="ltr" class="s2056829Normal"><span class="s2056829SCL">Source:</span><span xml:space="preserve" class="s2056829SCL-000003"> SL 1970, ch 229, § 8 (c); SDCL Supp, § 39-17-61; SL 1976, ch 158, § 42-15.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056830Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056830SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056830CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056830Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056830DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056830Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056830000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056830SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056830SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056830Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-19"><span class="s2056830SENU">34-20B-19</span></a><span xml:space="preserve" class="s2056830SENU">. </span><span class="s2056830CL">Stimulants specifically included in Schedule III.</span></p><p dir="ltr" class="s2056830Normal-000000"><span class="s2056830DefaultParagraphFont">Any material, compound, mixture, or preparation is included in Schedule III which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:</span></p><p dir="ltr" class="s2056830Normal-000001"><span class="s2056830DefaultParagraphFont">(1)    Benzphetamine;</span></p><p dir="ltr" class="s2056830Normal-000001"><span class="s2056830DefaultParagraphFont">(2)    Chlorphentermine;</span></p><p dir="ltr" class="s2056830Normal-000001"><span class="s2056830DefaultParagraphFont">(3)    Phendimetrazine;</span></p><p dir="ltr" class="s2056830Normal-000001"><span class="s2056830DefaultParagraphFont">(4)    Ephedrine.</span></p><p dir="ltr" class="s2056830Normal"><span xml:space="preserve" class="s2056830000002"> </span></p><p dir="ltr" class="s2056830Normal"><span class="s2056830SCL">Source:</span><span xml:space="preserve" class="s2056830SCL-000003"> SL 1970, ch 229, § 8 (c); SDCL Supp, § 39-17-62; SL 1977, ch 315, § 5; SL 1993, ch 247, § 3; SL 1995, ch 195, § 1; SL 1997, ch 202, § 1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056831Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056831SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056831CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056831Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056831DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056831000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056831SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056831SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056831Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-19.1"><span class="s2056831SENU">34-20B-19.1</span></a><span xml:space="preserve" class="s2056831SENU">. </span><span class="s2056831CL">Ephedrine defined.</span></p><p dir="ltr" class="s2056831Normal-000000"><span xml:space="preserve" class="s2056831DefaultParagraphFont">For the purposes of § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-19"><span class="s2056831DefaultParagraphFont">34-20B-19</span></a><span xml:space="preserve" class="s2056831DefaultParagraphFont">, the term, ephedrine includes ephedra, herbs and herbal products that contain ephedrine alkaloids, including ma huang, Chinese ephedra, ephedra sinica, ephedra herb powder, epitonin, or any extract of those substances, but the term does not include any drug that contains ephedrine and is lawfully sold, transferred, or furnished over the counter with or without a prescription pursuant to § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-21"><span class="s2056831DefaultParagraphFont">34-20B-21</span></a><span class="s2056831DefaultParagraphFont">.</span></p><p dir="ltr" class="s2056831Normal"><span xml:space="preserve" class="s2056831000001"> </span></p><p dir="ltr" class="s2056831Normal"><span class="s2056831SCL">Source:</span><span xml:space="preserve" class="s2056831SCL-000002"> SL 2004, ch 231, § 1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056832Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056832SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056832CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056832Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056832DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056832Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056832000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056832SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056832SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056832Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-20"><span class="s2056832SENU">34-20B-20</span></a><span xml:space="preserve" class="s2056832SENU">. </span><span class="s2056832CL">Depressants specifically included in Schedule III.</span></p><p dir="ltr" class="s2056832Normal-000000"><span class="s2056832DefaultParagraphFont">Any material, compound, mixture, or preparation is included in Schedule III that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(1)    Any substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances that are specifically listed in other schedules;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(2)    Chloral betaine;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(3)    Chloral hydrate;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(4)    Chlorhexadol;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(5)    Lysergic acid;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(6)    Lysergic acid amide;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(7)    Methyprylon;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(8)    Sulfondiethylmethane;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(9)    Sulfonethylmethane;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(10)    Sulfonmethane;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(11)    Amobarbital, pentobarbital, and secobarbital in suppository dosage form;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(12)    Gamma hydroxy butyrate;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(13)    Dronabinol in sesame oil and encapsulated in a gelatin capsule in a drug product approved for marketing by the United States Food and Drug Administration;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(14)    Buprenorphine;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(15)    Embutramide;</span></p><p dir="ltr" class="s2056832Normal-000001"><span class="s2056832DefaultParagraphFont">(16)    Perampanel [2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl) benzonitrile], including its salts, isomers, and salts of isomers.</span></p><p dir="ltr" class="s2056832Normal"><span xml:space="preserve" class="s2056832000002"> </span></p><p dir="ltr" class="s2056832Normal"><span class="s2056832SCL">Source:</span><span xml:space="preserve" class="s2056832SCL-000003"> SL 1970, ch 229, § 8 (c) (1); SDCL Supp, § 39-17-63; SL 1973, ch 260; SL 1979, ch 238, § 2; SL 1980, ch 240, § 1; SL 1992, ch 245, § 2; SL 1993, ch 247, § 4; SL 1999, ch 174, § 1; SL 2000, ch 170, § 2; SL 2003, ch 183, § 3; SL 2007, ch 194, § 2, eff. Feb. 1, 2007; SL 2014, ch 165, § 2, eff. Feb. 10, 2014; SL 2018, ch 203, § 4, eff. Feb. 8, 2018.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056833Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056833SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056833CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056833Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056833DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056833000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056833SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056833SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056833Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-20.1"><span class="s2056833SENU">34-20B-20.1</span></a><span xml:space="preserve" class="s2056833SENU">. </span><span class="s2056833CL">Gamma hydroxyl butyrate defined.</span></p><p dir="ltr" class="s2056833Normal-000000"><span xml:space="preserve" class="s2056833DefaultParagraphFont">For the purposes of § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-20"><span class="s2056833DefaultParagraphFont">34-20B-20</span></a><span class="s2056833DefaultParagraphFont">, the term, gamma hydroxyl butyrate, includes gamma-butyrolactone, 1,4-butanediol or any other substances which convert to gamma hydroxyl butyrate upon ingestion. However, the term does not include any product which is lawfully used for mechanical, industrial, manufacturing, or scientific purposes.</span></p><p dir="ltr" class="s2056833Normal"><span xml:space="preserve" class="s2056833000001"> </span></p><p dir="ltr" class="s2056833Normal"><span class="s2056833SCL">Source:</span><span xml:space="preserve" class="s2056833SCL-000002"> SL 2006, ch 180, § 1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s77cd360bd5cb4f55ab58ea6c1472393eNormal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s77cd360bd5cb4f55ab58ea6c1472393eSENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s77cd360bd5cb4f55ab58ea6c1472393eNormal-000001 { margin-left: 1.00in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s77cd360bd5cb4f55ab58ea6c1472393eNormal-000002 { margin-left: 1.50in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s77cd360bd5cb4f55ab58ea6c1472393e000003 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s77cd360bd5cb4f55ab58ea6c1472393eSCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-20.2 - Xylazine--Permissible uses."><meta property="og:description" content="SDLRC Codified Law 34-20B-20.2 - Xylazine--Permissible uses."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-20.2"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-20.2" rel="noopener"><span class="s77cd360bd5cb4f55ab58ea6c1472393eSENU">34-20B-20.2</span></a><span xml:space="preserve" class="s77cd360bd5cb4f55ab58ea6c1472393eSENU">. </span><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont">Xylazine--Permissible uses.</span><span xml:space="preserve" class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">    </span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">Any material, compound, mixture, or preparation that contains xylazine is a Schedule III controlled drug or substance, except in the following cases:</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000001"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(1)    Dispensing, prescribing, or administering, to an animal, a drug containing xylazine that has been approved by the United States secretary of health and human services under 21 U.S.C. § 360b (January 1, 2024);</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000001"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(2)    Dispensing, prescribing, or administering xylazine to an animal that is permissible under 21 U.S.C. § 360b(a)(4) (January 1, 2024);</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000001"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(3)    Manufacturing, distributing, or using xylazine as an active pharmaceutical ingredient for manufacturing an animal drug:</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000002"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(a)    Approved under 21 U.S.C. § 360b (January 1, 2024); or</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000002"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(b)    Issued an investigation use exemption under 21 U.S.C. § 360b(j) (January 1, 2024);</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000001"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(4)    Manufacturing, distributing, or using a xylazine bulk chemical for pharmaceutical compounding by a licensed pharmacist or veterinarian; or</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal-000001"><span class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont-000000">(5)    Any other use approved or permissible under 21 U.S.C. § 301, et seq. (January 1, 2024).</span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal"><span xml:space="preserve" class="s77cd360bd5cb4f55ab58ea6c1472393e000003"> </span></p><p dir="ltr" class="s77cd360bd5cb4f55ab58ea6c1472393eNormal"><span xml:space="preserve" class="s77cd360bd5cb4f55ab58ea6c1472393eDefaultParagraphFont">Source: </span><span class="s77cd360bd5cb4f55ab58ea6c1472393eSCL">SL 2024, ch 131, § 1, eff. Feb. 12, 2024.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056834Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056834SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056834CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056834Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056834DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056834000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056834SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056834SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056834Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-21"><span class="s2056834SENU">34-20B-21</span></a><span xml:space="preserve" class="s2056834SENU">. </span><span class="s2056834CL">Exception from Schedule III of stimulants and depressants used in medicinal preparations.</span></p><p dir="ltr" class="s2056834Normal-000000"><span xml:space="preserve" class="s2056834DefaultParagraphFont">The department may by rules promulgated pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=1-26"><span class="s2056834DefaultParagraphFont">1-26</span></a><span xml:space="preserve" class="s2056834DefaultParagraphFont"> except any compound, mixture, or preparation containing any stimulant, depressant substance, or anabolic steroid listed in §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-19"><span class="s2056834DefaultParagraphFont">34-20B-19</span></a><span xml:space="preserve" class="s2056834DefaultParagraphFont">, </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-20"><span class="s2056834DefaultParagraphFont">34-20B-20</span></a><span xml:space="preserve" class="s2056834DefaultParagraphFont">, and </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-22"><span class="s2056834DefaultParagraphFont">34-20B-22</span></a><span xml:space="preserve" class="s2056834DefaultParagraphFont"> if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant, depressant, or anabolic steroid effect. Such admixtures shall be included therein in such combinations, quantity, proportion, or concentration as to vitiate the potential for abuse of the substances which do have a stimulant, depressant, or anabolic steroid effect.</span></p><p dir="ltr" class="s2056834Normal"><span xml:space="preserve" class="s2056834000001"> </span></p><p dir="ltr" class="s2056834Normal"><span class="s2056834SCL">Source:</span><span xml:space="preserve" class="s2056834SCL-000002"> SL 1970, ch 229, § 8 (c); SDCL Supp, § 39-17-64; SL 1993, ch 247, § 5; SL 1997, ch 202, § 2.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056835Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056835SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056835CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056835Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056835DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056835Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056835000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056835SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056835SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056835Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-22"><span class="s2056835SENU">34-20B-22</span></a><span xml:space="preserve" class="s2056835SENU">. </span><span class="s2056835CL">Specific substances included in Schedule III.</span></p><p dir="ltr" class="s2056835Normal-000000"><span class="s2056835DefaultParagraphFont">The following are included in Schedule III:</span></p><p dir="ltr" class="s2056835Normal-000001"><span class="s2056835DefaultParagraphFont">(1)    Nalorphine;</span></p><p dir="ltr" class="s2056835Normal-000001"><span class="s2056835DefaultParagraphFont">(2)    Preparations which contain both Tiletamine and Zolazepam;</span></p><p dir="ltr" class="s2056835Normal-000001"><span xml:space="preserve" class="s2056835DefaultParagraphFont">(3)    Anabolic steroids as listed in § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-4.1"><span class="s2056835DefaultParagraphFont">34-20B-4.1</span></a><span class="s2056835DefaultParagraphFont">;</span></p><p dir="ltr" class="s2056835Normal-000001"><span class="s2056835DefaultParagraphFont">(4)    Ketamine.</span></p><p dir="ltr" class="s2056835Normal"><span xml:space="preserve" class="s2056835000002"> </span></p><p dir="ltr" class="s2056835Normal"><span class="s2056835SCL">Source:</span><span xml:space="preserve" class="s2056835SCL-000003"> SL 1970, ch 229, § 8 (c); SDCL Supp, § 39-17-65; SL 1971, ch 224, §§ 1, 2; SL 1988, ch 282, § 3; SL 1992, ch 245, § 5; SL 1993, ch 247, § 6; SL 2000, ch 170, § 3.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056836Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056836SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056836CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056836Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056836DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056836Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056836000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056836SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056836SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056836Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-23"><span class="s2056836SENU">34-20B-23</span></a><span xml:space="preserve" class="s2056836SENU">. </span><span class="s2056836CL">Narcotics specifically included in Schedule III.</span></p><p dir="ltr" class="s2056836Normal-000000"><span class="s2056836DefaultParagraphFont">Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof is included in Schedule III:</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(1)    Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of isoquinoline alkaloid of opium;</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(2)    Not more than 1.80 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(3)    Deleted by SL 2015, ch 180, § 4;</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(4)    Deleted by SL 2015, ch 180, § 4;</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(5)    Not more than 1.80 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(6)    Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts;</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(7)    Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts; and</span></p><p dir="ltr" class="s2056836Normal-000001"><span class="s2056836DefaultParagraphFont">(8)    Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic ingredients in recognized therapeutic amounts.</span></p><p dir="ltr" class="s2056836Normal"><span xml:space="preserve" class="s2056836000002"> </span></p><p dir="ltr" class="s2056836Normal"><span class="s2056836SCL">Source:</span><span xml:space="preserve" class="s2056836SCL-000003"> SL 1970, ch 229, § 8 (c); SDCL Supp, § 39-17-66; SL 2015, ch 180, § 4, eff. Feb. 18, 2015.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056837Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056837SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056837CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056837Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056837DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056837Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056837000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056837SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056837SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056837Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-24"><span class="s2056837SENU">34-20B-24</span></a><span xml:space="preserve" class="s2056837SENU">. </span><span class="s2056837CL">Criteria for inclusion of substances in Schedule IV.</span></p><p dir="ltr" class="s2056837Normal-000000"><span class="s2056837DefaultParagraphFont">To be included within Schedule IV, a substance shall have:</span></p><p dir="ltr" class="s2056837Normal-000001"><span class="s2056837DefaultParagraphFont">(1)    A low potential for abuse relative to the substances listed in Schedule III;</span></p><p dir="ltr" class="s2056837Normal-000001"><span class="s2056837DefaultParagraphFont">(2)    Currently accepted medical use in the United States; and</span></p><p dir="ltr" class="s2056837Normal-000001"><span class="s2056837DefaultParagraphFont">(3)    Limited physical dependence or psychological dependence liability or potential, or both, relative to the substances listed in Schedule III.</span></p><p dir="ltr" class="s2056837Normal"><span xml:space="preserve" class="s2056837000002"> </span></p><p dir="ltr" class="s2056837Normal"><span class="s2056837SCL">Source:</span><span xml:space="preserve" class="s2056837SCL-000003"> SL 1970, ch 229, § 8 (d); SDCL Supp, § 39-17-67; SL 1976, ch 158, § 42-16.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.sfcd94dbcd1b34e47a7fffd820aa4f452Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sfcd94dbcd1b34e47a7fffd820aa4f452SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sfcd94dbcd1b34e47a7fffd820aa4f452CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.sfcd94dbcd1b34e47a7fffd820aa4f452Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1 { margin-left: 0.75in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } a.sfcd94dbcd1b34e47a7fffd820aa4f452000000 { text-decoration: none; } p.sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1-000001 { margin-left: 0.69in; text-indent: -0.38in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.sfcd94dbcd1b34e47a7fffd820aa4f452000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sfcd94dbcd1b34e47a7fffd820aa4f452NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sfcd94dbcd1b34e47a7fffd820aa4f452SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-25 - Substances included in Schedule IV."><meta property="og:description" content="SDLRC Codified Law 34-20B-25 - Substances included in Schedule IV."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-25"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-25" rel="noopener"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452SENU">34-20B-25</span></a><span xml:space="preserve" class="sfcd94dbcd1b34e47a7fffd820aa4f452SENU">. </span><span class="sfcd94dbcd1b34e47a7fffd820aa4f452CL">Substances included in Schedule IV.</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452Statute"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">The following are included in Schedule IV:</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(1)    Chlordiazepoxide, but not including librax (chlordiazepoxide hydrochloride and clindinium bromide) or menrium (chlordiazepoxide and water soluble esterified estrogens);</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(2)    Clonazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(3)    Clorazepate;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(4)    Diazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(5)    Flunitrazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(6)    Flurazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(7)    Mebutamate;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(8)    Oxazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(9)    Prazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(10)    Lorazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(11)    Triazolam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(12)    Any substance that contains any quantity of a benzodiazepine, or salt of benzodiazepine, except substances that are specifically listed in other schedules;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(13)    Alprazolam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(14)    Midazolam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(15)    Temazepam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(16)    Cathine;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(17)    Fencamfamine;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(18)    Fenproporex;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(19)    Mefenorex;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(20)    Pyrovalerone;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(21)    Propoxyphene;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(22)    Pentazocine;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(23)    Diethylpropion;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(24)    Ethchlorvynol;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(25)    Ethinamate;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(26)    Mazindol;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(27)    Mephobarbital;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(28)    Methohexitol;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span lang="fr-FR" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(29)    Paraldehyde;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span lang="fr-FR" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(30)    Pemoline;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span lang="fr-FR" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(31)    Petrichloral;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span lang="fr-FR" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(32)    Phentermine;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span lang="fr-FR" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(33)    Barbital;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(34)    Phenobarbital;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(35)    Meprobamate;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(36)    Zolpidem;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(37)    Butorphanol;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(38)    Modafinil, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(39)    Sibutramine;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(40)    Zaleplon;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(41)    Dichloralphenazone;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(42)    Zopiclone, also known as eszopiclone, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(43)    Pregabalin;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(44)    Lacosamide;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(45)    Fospropofol, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(46)    Clobazam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(47)    Carisoprodol, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(48)    Ezogabine,[-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester], including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(49)    Lorcaserin, any material, compound, mixture, or preparation that contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(50)    Alfaxalone, 5[alpha]-pregnan-3[alpha]-ol-11,20-dione, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(51)    Tramadol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(52)    Suvorexant, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(53)    Eluxadoline,(5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) including its optical isomers and its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(54)    Brivaracetam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span xml:space="preserve" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(55)    </span><a id="_pagenumber7" class="sfcd94dbcd1b34e47a7fffd820aa4f452000000" rel="noopener"></a><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)), including its salts, isomers, and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(56)    Brexanolone, (3[alpha]-hydroxy-5[alpha]-pregnan-20-one), including its salts, isomers, and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(57)    Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester);</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(58)    Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl)-benzamide];</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(59)    Lemborexant, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(60)    Remimazolam;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(61)    Serdexmethylphenidate, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1-000001"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(62)    Daridorexant, including its salts, isomers, and salts of isomers;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1-000001"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(63)    Ganaxolone, including its salts;</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452StatuteNumber1-000001"><span class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont">(64)    Zuranolone.</span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452Normal"><span xml:space="preserve" class="sfcd94dbcd1b34e47a7fffd820aa4f452000002"> </span></p><p dir="ltr" class="sfcd94dbcd1b34e47a7fffd820aa4f452NoIndent"><span xml:space="preserve" class="sfcd94dbcd1b34e47a7fffd820aa4f452DefaultParagraphFont-000003">Source: </span><span class="sfcd94dbcd1b34e47a7fffd820aa4f452SCL">SL 1977, ch 315, § 6; SL 1978, ch 249, §§ 2, 3; SL 1980, ch 240, § 2; SL 1981, ch 261, § 3; SL 1985, ch 278, § 53; SL 1987, ch 255; SL 1989, ch 293, § 4; SL 1990, ch 270, § 2; SL 1992, ch 245, § 3; SL 1993, ch 247, § 7; SL 1994, ch 278, § 4; SL 1995, ch 191, § 2; SL 1999, ch 174, § 2; SL 2000, ch 170, § 4; SL 2002, ch 167, § 2; SL 2003, ch 183, § 4; SL 2006, ch 179, § 2, eff. Feb. 9, 2006; SL 2010, ch 174, § 3, eff. Feb. 24, 2010; SL 2012, ch 183, § 3, eff. Feb. 23, 2012; SL 2013, ch 156, § 5, eff. Mar. 6, 2013; SL 2015, ch 180, § 5, eff. Feb. 18, 2015; SL 2016, ch 175, § 4, eff. Feb. 18, 2016; SL 2017, ch 156, § 3, eff. Feb. 3, 2017; SL 2017, ch 155, § 2; SL 2019, ch 148, § 4, eff. Feb. 19, 2019; SL 2020, ch 144, § 3, eff. Mar. 9, 2020; SL 2021, ch 144, § 6, eff. Feb. 17, 2021; SL 2022, ch 109, § 4, eff. Feb. 9, 2022; SL 2023, ch 119, § 3, eff. Feb. 9, 2023; SL 2024, ch 130, § 3, eff. Feb. 14, 2024.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056839Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056839SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056839CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056839Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056839DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056839Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056839000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056839SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056839SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056839Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2056839SENU">34-20B-26</span></a><span xml:space="preserve" class="s2056839SENU">. </span><span class="s2056839CL">Narcotic compounds specifically included in Schedule IV.</span></p><p dir="ltr" class="s2056839Normal-000000"><span class="s2056839DefaultParagraphFont">Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs is included in Schedule IV which shall include one or more non-narcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:</span></p><p dir="ltr" class="s2056839Normal-000001"><span class="s2056839DefaultParagraphFont">(1)    Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;</span></p><p dir="ltr" class="s2056839Normal-000001"><span class="s2056839DefaultParagraphFont">(2)    Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;</span></p><p dir="ltr" class="s2056839Normal-000001"><span class="s2056839DefaultParagraphFont">(3)    Not more than 50 milligrams of ethylmorphine per 100 milliliters or per 100 grams;</span></p><p dir="ltr" class="s2056839Normal-000001"><span class="s2056839DefaultParagraphFont">(4)    Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;</span></p><p dir="ltr" class="s2056839Normal-000001"><span class="s2056839DefaultParagraphFont">(5)    Not more than 100 milligrams of opium per 100 milliliters or per 100 grams, or not more than 5 milligrams per dosage unit; and</span></p><p dir="ltr" class="s2056839Normal-000001"><span class="s2056839DefaultParagraphFont">(6)    Not more than 1 milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.</span></p><p dir="ltr" class="s2056839Normal"><span xml:space="preserve" class="s2056839000002"> </span></p><p dir="ltr" class="s2056839Normal"><span class="s2056839SCL">Source:</span><span xml:space="preserve" class="s2056839SCL-000003"> SL 1970, ch 229, § 8 (d) (1); SDCL Supp, § 39-17-68; SL 1980, ch 240, § 3; SL 1981, ch 261, § 2; SL 1990, ch 270, § 3; SL 2015, ch 180, § 6, eff. Feb. 18, 2015.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056840Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056840SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056840CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056840Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056840DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056840000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056840SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056840SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056840Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-27"><span class="s2056840SENU">34-20B-27</span></a><span xml:space="preserve" class="s2056840SENU">. </span><span class="s2056840CL">Recommendations for addition, deletion, or rescheduling of scheduled substances.</span></p><p dir="ltr" class="s2056840Normal-000000"><span class="s2056840DefaultParagraphFont">The department shall make recommendations to the Legislature that a substance be added, deleted, or rescheduled when the department determines that such substance has a different potential for abuse.</span></p><p dir="ltr" class="s2056840Normal"><span xml:space="preserve" class="s2056840000001"> </span></p><p dir="ltr" class="s2056840Normal"><span class="s2056840SCL">Source:</span><span xml:space="preserve" class="s2056840SCL-000002"> SL 1970, ch 229, § 7 (a); SDCL Supp, § 39-17-69; 9SL 1976, ch 158, § 42-17.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056841Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056841SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056841CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056841Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056841DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056841000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056841SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056841SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056841Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28"><span class="s2056841SENU">34-20B-28</span></a><span xml:space="preserve" class="s2056841SENU">. </span><span class="s2056841CL">Substances not subject to control as precursors of precursors.</span></p><p dir="ltr" class="s2056841Normal-000000"><span class="s2056841DefaultParagraphFont">If the department designates a substance as an "immediate precursor," substances which are precursors of such designated immediate precursors shall not be subject to control solely because they are precursors of the controlled precursor.</span></p><p dir="ltr" class="s2056841Normal"><span xml:space="preserve" class="s2056841000001"> </span></p><p dir="ltr" class="s2056841Normal"><span class="s2056841SCL">Source:</span><span xml:space="preserve" class="s2056841SCL-000002"> SL 1970, ch 229, § 7 (c); SDCL Supp, § 39-17-71.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056842Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056842SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056842CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056842Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056842DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056842Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056842000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056842SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056842SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056842Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.1"><span class="s2056842SENU">34-20B-28.1</span></a><span xml:space="preserve" class="s2056842SENU">. </span><span class="s2056842CL">Definition of terms applicable to code imprinted drugs.</span></p><p dir="ltr" class="s2056842Normal-000000"><span xml:space="preserve" class="s2056842DefaultParagraphFont">Terms used in §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.2"><span class="s2056842DefaultParagraphFont">34-20B-28.2</span></a><span xml:space="preserve" class="s2056842DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.6"><span class="s2056842DefaultParagraphFont">34-20B-28.6</span></a><span class="s2056842DefaultParagraphFont">, inclusive, unless the context plainly otherwise requires, mean:</span></p><p dir="ltr" class="s2056842Normal-000001"><span class="s2056842DefaultParagraphFont">(1)    "Code imprint," a series of letters or numbers assigned by the manufacturer or distributor to a specific drug, or marks or monograms unique to the manufacturer or distributor of the drug, or both;</span></p><p dir="ltr" class="s2056842Normal-000001"><span class="s2056842DefaultParagraphFont">(2)    "Distributor," a person who distributes for resale a drug in solid dosage form under his own label even though he is not the actual manufacturer of the drug;</span></p><p dir="ltr" class="s2056842Normal-000001"><span class="s2056842DefaultParagraphFont">(3)    "Legend drug," any drug defined by section 503(b) of the Federal Food, Drug and Cosmetic Act, as amended on January 15, 1980, and under which definition its label is required to bear the statement "Caution: Federal law prohibits dispensing without prescription";</span></p><p dir="ltr" class="s2056842Normal-000001"><span class="s2056842DefaultParagraphFont">(4)    "Solid dosage form," capsules or tablets intended for oral use.</span></p><p dir="ltr" class="s2056842Normal"><span xml:space="preserve" class="s2056842000002"> </span></p><p dir="ltr" class="s2056842Normal"><span class="s2056842SCL">Source:</span><span xml:space="preserve" class="s2056842SCL-000003"> SL 1980, ch 241, § 1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056843Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056843SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056843CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056843Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056843DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056843000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056843SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056843SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056843Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.2"><span class="s2056843SENU">34-20B-28.2</span></a><span xml:space="preserve" class="s2056843SENU">. </span><span class="s2056843CL">Code imprint required.</span></p><p dir="ltr" class="s2056843Normal-000000"><span class="s2056843DefaultParagraphFont">No legend drug in solid dosage form may be manufactured or distributed in this state unless it is clearly marked or imprinted with a code imprint identifying the drug and the manufacturer or distributor of the drug.</span></p><p dir="ltr" class="s2056843Normal"><span xml:space="preserve" class="s2056843000001"> </span></p><p dir="ltr" class="s2056843Normal"><span class="s2056843SCL">Source:</span><span xml:space="preserve" class="s2056843SCL-000002"> SL 1980, ch 241, § 2.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056844Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056844SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056844CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056844Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056844DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056844000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056844SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056844SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056844Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.3"><span class="s2056844SENU">34-20B-28.3</span></a><span xml:space="preserve" class="s2056844SENU">. </span><span class="s2056844CL">Manufacturers' and distributors' identifying listings.</span></p><p dir="ltr" class="s2056844Normal-000000"><span xml:space="preserve" class="s2056844DefaultParagraphFont">All manufacturers and distributors of legend drugs in solid dosage form shall provide upon request to the Board of Pharmacy a listing of all such legend drugs identifying by code imprint the manufacturer and the specific type of drug. Such listing shall at all times be kept current by all manufacturers and distributors subject to §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.1"><span class="s2056844DefaultParagraphFont">34-20B-28.1</span></a><span xml:space="preserve" class="s2056844DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.6"><span class="s2056844DefaultParagraphFont">34-20B-28.6</span></a><span class="s2056844DefaultParagraphFont">, inclusive.</span></p><p dir="ltr" class="s2056844Normal"><span xml:space="preserve" class="s2056844000001"> </span></p><p dir="ltr" class="s2056844Normal"><span class="s2056844SCL">Source:</span><span xml:space="preserve" class="s2056844SCL-000002"> SL 1980, ch 241, § 3.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056845Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056845SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056845CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056845Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056845DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056845000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056845SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056845SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056845Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.4"><span class="s2056845SENU">34-20B-28.4</span></a><span xml:space="preserve" class="s2056845SENU">. </span><span class="s2056845CL">Exemptions--Granting on appropriate showing--Inclusion in listings.</span></p><p dir="ltr" class="s2056845Normal-000000"><span xml:space="preserve" class="s2056845DefaultParagraphFont">The Board of Pharmacy may grant exemptions from the requirements of §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.1"><span class="s2056845DefaultParagraphFont">34-20B-28.1</span></a><span xml:space="preserve" class="s2056845DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.6"><span class="s2056845DefaultParagraphFont">34-20B-28.6</span></a><span xml:space="preserve" class="s2056845DefaultParagraphFont">, inclusive, upon application by any drug manufacturer or distributor showing size, physical characteristics, or other unique characteristics which render the application of a code imprint to a legend drug subject to §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.1"><span class="s2056845DefaultParagraphFont">34-20B-28.1</span></a><span xml:space="preserve" class="s2056845DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.6"><span class="s2056845DefaultParagraphFont">34-20B-28.6</span></a><span xml:space="preserve" class="s2056845DefaultParagraphFont">, inclusive, impractical or impossible. Any such exemption granted by the board shall be included by the manufacturer or distributor in the listing required by § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.3"><span class="s2056845DefaultParagraphFont">34-20B-28.3</span></a><span class="s2056845DefaultParagraphFont">, describing the physical characteristics and type of drug to which the exemption relates.</span></p><p dir="ltr" class="s2056845Normal"><span xml:space="preserve" class="s2056845000001"> </span></p><p dir="ltr" class="s2056845Normal"><span class="s2056845SCL">Source:</span><span xml:space="preserve" class="s2056845SCL-000002"> SL 1980, ch 241, § 4.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056846Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056846SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056846CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056846Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056846DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056846000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056846SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056846SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056846Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.5"><span class="s2056846SENU">34-20B-28.5</span></a><span xml:space="preserve" class="s2056846SENU">. </span><span class="s2056846CL">Contraband--Seizure and forfeiture.</span></p><p dir="ltr" class="s2056846Normal-000000"><span xml:space="preserve" class="s2056846DefaultParagraphFont">All legend drugs in solid dosage form that are possessed, distributed, sold, or offered for sale in violation of the provisions of §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.1"><span class="s2056846DefaultParagraphFont">34-20B-28.1</span></a><span xml:space="preserve" class="s2056846DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.6"><span class="s2056846DefaultParagraphFont">34-20B-28.6</span></a><span class="s2056846DefaultParagraphFont">, inclusive, shall be deemed contraband and shall be seized by the Board of Pharmacy and summarily forfeited to the state.</span></p><p dir="ltr" class="s2056846Normal"><span xml:space="preserve" class="s2056846000001"> </span></p><p dir="ltr" class="s2056846Normal"><span class="s2056846SCL">Source:</span><span xml:space="preserve" class="s2056846SCL-000002"> SL 1980, ch 241, § 5.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056847Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056847SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056847CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056847Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056847DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056847000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056847SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056847SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056847Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.6"><span class="s2056847SENU">34-20B-28.6</span></a><span xml:space="preserve" class="s2056847SENU">. </span><span class="s2056847CL">Dispensing or sale without code imprint--Misdemeanor.</span></p><p dir="ltr" class="s2056847Normal-000000"><span xml:space="preserve" class="s2056847DefaultParagraphFont">It is a Class 2 misdemeanor for a person to dispense, sell or otherwise provide to any other person any legend drug in solid dosage form that fails to comply with §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.1"><span class="s2056847DefaultParagraphFont">34-20B-28.1</span></a><span xml:space="preserve" class="s2056847DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-28.5"><span class="s2056847DefaultParagraphFont">34-20B-28.5</span></a><span class="s2056847DefaultParagraphFont">, inclusive.</span></p><p dir="ltr" class="s2056847Normal"><span xml:space="preserve" class="s2056847000001"> </span></p><p dir="ltr" class="s2056847Normal"><span class="s2056847SCL">Source:</span><span xml:space="preserve" class="s2056847SCL-000002"> SL 1980, ch 241, § 6.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056848Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056848SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056848CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056848Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056848DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056848000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056848SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056848SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056848Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-29"><span class="s2056848SENU">34-20B-29</span></a><span xml:space="preserve" class="s2056848SENU">. </span><span class="s2056848CL">Registration of prescribers, manufacturers, distributors, and dispensers of controlled drug or substance.</span></p><p dir="ltr" class="s2056848Normal-000000"><span class="s2056848DefaultParagraphFont">Any person who prescribes, manufactures, distributes, or dispenses any controlled drug or substance within this state or who proposes to engage in the prescribing, manufacture, distribution, or dispensing of any controlled drug or substance within this state, shall obtain a registration issued by the department according to the rules promulgated under this chapter.</span></p><p dir="ltr" class="s2056848Normal"><span xml:space="preserve" class="s2056848000001"> </span></p><p dir="ltr" class="s2056848Normal"><span class="s2056848SCL">Source:</span><span xml:space="preserve" class="s2056848SCL-000002"> SL 1970, ch 229, § 9 (a); SDCL Supp, § 39-17-72; SL 1995, ch 191, § 3; SL 2004, ch 229, § 2.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056849Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056849SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056849CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056849Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056849DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056849Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056849000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056849SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056849SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056849Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-30"><span class="s2056849SENU">34-20B-30</span></a><span xml:space="preserve" class="s2056849SENU">. </span><span class="s2056849CL">Exemptions from annual registration requirements.</span></p><p dir="ltr" class="s2056849Normal-000000"><span xml:space="preserve" class="s2056849DefaultParagraphFont">The following persons shall not be required to register under the provisions of § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-29"><span class="s2056849DefaultParagraphFont">34-20B-29</span></a><span class="s2056849DefaultParagraphFont">:</span></p><p dir="ltr" class="s2056849Normal-000001"><span class="s2056849DefaultParagraphFont">(1)    An agent, or an employee thereof, of any manufacturer, distributor, or dispenser of any controlled drug or substance if such agent is acting in the usual course of his business or employment;</span></p><p dir="ltr" class="s2056849Normal-000001"><span class="s2056849DefaultParagraphFont">(2)    A common or contract carrier or warehouseman, or an employee thereof, whose possession of any controlled drug or substance is in the usual course of his business or employment;</span></p><p dir="ltr" class="s2056849Normal-000001"><span class="s2056849DefaultParagraphFont">(3)    A person in possession of any controlled drug or substance pursuant to a lawful order of a practitioner.</span></p><p dir="ltr" class="s2056849Normal"><span xml:space="preserve" class="s2056849000002"> </span></p><p dir="ltr" class="s2056849Normal"><span class="s2056849SCL">Source:</span><span xml:space="preserve" class="s2056849SCL-000003"> SL 1970, ch 229, § 9 (b); SDCL Supp, § 39-17-73.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-31 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-31 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-31"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-31. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 2004, ch 232, &#167;&nbsp;2.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056851Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056851SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056851CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056851Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056851DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056851000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056851SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056851SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056851Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-32"><span class="s2056851SENU">34-20B-32</span></a><span xml:space="preserve" class="s2056851SENU">. </span><span class="s2056851CL">Waiver of registration requirement by regulation.</span></p><p dir="ltr" class="s2056851Normal-000000"><span class="s2056851DefaultParagraphFont">The department may, by regulation, waive the requirement for registration of certain manufacturers, distributors, or dispensers if the department finds it consistent with the public health and safety.</span></p><p dir="ltr" class="s2056851Normal"><span xml:space="preserve" class="s2056851000001"> </span></p><p dir="ltr" class="s2056851Normal"><span class="s2056851SCL">Source:</span><span xml:space="preserve" class="s2056851SCL-000002"> SL 1970, ch 229, § 9 (c); SDCL Supp, § 39-17-75.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056852Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056852SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056852CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056852Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056852DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056852000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056852SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056852SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056852Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-33"><span class="s2056852SENU">34-20B-33</span></a><span xml:space="preserve" class="s2056852SENU">. </span><span class="s2056852CL">Registration of previously registered or licensed establishments.</span></p><p dir="ltr" class="s2056852Normal-000000"><span class="s2056852DefaultParagraphFont">The department shall permit persons to register who own or operate any establishment engaged in the manufacture, distribution, or dispensing of any controlled drugs and substances prior to July 1, 1972, and who are registered or licensed by the state.</span></p><p dir="ltr" class="s2056852Normal"><span xml:space="preserve" class="s2056852000001"> </span></p><p dir="ltr" class="s2056852Normal"><span class="s2056852SCL">Source:</span><span xml:space="preserve" class="s2056852SCL-000002"> SL 1970, ch 229, § 9 (i); SDCL Supp, § 39-17-76.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056853Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056853SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056853CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056853Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056853DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056853000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056853SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056853SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056853Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-34"><span class="s2056853SENU">34-20B-34</span></a><span xml:space="preserve" class="s2056853SENU">. </span><span class="s2056853CL">Separate registration required for each place of business or practice.</span></p><p dir="ltr" class="s2056853Normal-000000"><span class="s2056853DefaultParagraphFont">A separate registration shall be required at each principal place of business or professional practice where the applicant manufactures, distributes, or dispenses controlled drugs and substances.</span></p><p dir="ltr" class="s2056853Normal"><span xml:space="preserve" class="s2056853000001"> </span></p><p dir="ltr" class="s2056853Normal"><span class="s2056853SCL">Source:</span><span xml:space="preserve" class="s2056853SCL-000002"> SL 1970, ch 229, § 9 (d); SDCL Supp, § 39-17-77.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056854Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056854SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056854CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056854Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056854DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056854Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056854000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056854SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056854SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056854Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-35"><span class="s2056854SENU">34-20B-35</span></a><span xml:space="preserve" class="s2056854SENU">. </span><span class="s2056854CL">Criteria for registration of manufacturers and distributors.</span></p><p dir="ltr" class="s2056854Normal-000000"><span xml:space="preserve" class="s2056854DefaultParagraphFont">The department shall register an applicant to manufacture and distribute controlled drugs and substances included in Schedules I through IV of §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-11"><span class="s2056854DefaultParagraphFont">34-20B-11</span></a><span xml:space="preserve" class="s2056854DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-26"><span class="s2056854DefaultParagraphFont">34-20B-26</span></a><span class="s2056854DefaultParagraphFont">, inclusive, unless it is determined that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</span></p><p dir="ltr" class="s2056854Normal-000001"><span class="s2056854DefaultParagraphFont">(1)    Maintenance of effective controls against diversion of particular controlled drugs and substances and any Schedule I or II substance compounded therefrom into other than legitimate medical, scientific, or industrial channels;</span></p><p dir="ltr" class="s2056854Normal-000001"><span class="s2056854DefaultParagraphFont">(2)    Compliance with the applicable state and local law;</span></p><p dir="ltr" class="s2056854Normal-000001"><span class="s2056854DefaultParagraphFont">(3)    Prior conviction record of applicant under federal and state laws relating to the manufacture, distribution, or dispensing of such substances;</span></p><p dir="ltr" class="s2056854Normal-000001"><span class="s2056854DefaultParagraphFont">(4)    Past experience in the manufacture of controlled drugs and substances, and the existence in the establishment of effective controls against diversion; and</span></p><p dir="ltr" class="s2056854Normal-000001"><span class="s2056854DefaultParagraphFont">(5)    Such other factors as may be relevant to and consistent with the public health and safety.</span></p><p dir="ltr" class="s2056854Normal"><span xml:space="preserve" class="s2056854000002"> </span></p><p dir="ltr" class="s2056854Normal"><span class="s2056854SCL">Source:</span><span xml:space="preserve" class="s2056854SCL-000003"> SL 1970, ch 229, § 9 (f); SDCL Supp, § 39-17-78.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056855Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056855SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056855CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056855Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056855DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056855000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056855SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056855SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056855Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-36"><span class="s2056855SENU">34-20B-36</span></a><span xml:space="preserve" class="s2056855SENU">. </span><span class="s2056855CL">Authorized Schedule I and II substances to be specified in manufacturer's or distributor's registration.</span></p><p dir="ltr" class="s2056855Normal-000000"><span xml:space="preserve" class="s2056855DefaultParagraphFont">Registration granted under § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-29"><span class="s2056855DefaultParagraphFont">34-20B-29</span></a><span xml:space="preserve" class="s2056855DefaultParagraphFont"> shall not entitle a registrant to manufacture and distribute controlled drugs and substances in Schedules I and II other than those specified in the registration.</span></p><p dir="ltr" class="s2056855Normal"><span xml:space="preserve" class="s2056855000001"> </span></p><p dir="ltr" class="s2056855Normal"><span class="s2056855SCL">Source:</span><span xml:space="preserve" class="s2056855SCL-000002"> SL 1970, ch 229, § 9 (g); SDCL Supp, § 39-17-79.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056856Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056856SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056856CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056856Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056856DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056856000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056856SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056856SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056856Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-37"><span class="s2056856SENU">34-20B-37</span></a><span xml:space="preserve" class="s2056856SENU">. </span><span class="s2056856CL">Practitioners registered to dispense Schedule II, III, and IV substances.</span></p><p dir="ltr" class="s2056856Normal-000000"><span class="s2056856DefaultParagraphFont">Practitioners shall be registered to dispense substances in Schedules II through IV if they are authorized to dispense under the law of this state.</span></p><p dir="ltr" class="s2056856Normal"><span xml:space="preserve" class="s2056856000001"> </span></p><p dir="ltr" class="s2056856Normal"><span class="s2056856SCL">Source:</span><span xml:space="preserve" class="s2056856SCL-000002"> SL 1970, ch 229, § 9 (h); SDCL Supp, § 39-17-80.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-38 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-38 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-38"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-38. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1989, ch 293, &#167;&nbsp;5.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056858Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056858SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056858CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056858Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056858DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056858000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056858SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056858SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056858Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-39"><span class="s2056858SENU">34-20B-39</span></a><span xml:space="preserve" class="s2056858SENU">. </span><span class="s2056858CL">Inventories and records of controlled substances required of registrants.</span></p><p dir="ltr" class="s2056858Normal-000000"><span class="s2056858DefaultParagraphFont">Each registrant manufacturing, distributing, or dispensing controlled drugs and substances in Schedules I, II, III, or IV shall maintain complete and accurate records of all stocks of such drugs and substances on hand. Records and inventories shall contain such information as shall be provided by rules and regulations promulgated by the department. All records required under this section shall be kept for a period of at least two years. This section shall not apply to practitioners who lawfully prescribe or administer, but not otherwise dispense, controlled drugs and substances listed in Schedules II, III, or IV of this chapter.</span></p><p dir="ltr" class="s2056858Normal"><span xml:space="preserve" class="s2056858000001"> </span></p><p dir="ltr" class="s2056858Normal"><span class="s2056858SCL">Source:</span><span xml:space="preserve" class="s2056858SCL-000002"> SL 1970, ch 229, § 9 (j); SDCL Supp, § 39-17-82.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056859Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056859SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056859CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056859Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056859DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056859000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056859SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056859SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056859Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-40"><span class="s2056859SENU">34-20B-40</span></a><span xml:space="preserve" class="s2056859SENU">. </span><span class="s2056859CL">Inspection of registrant's premises authorized.</span></p><p dir="ltr" class="s2056859Normal-000000"><span xml:space="preserve" class="s2056859DefaultParagraphFont">The department is authorized to inspect the establishment of a registrant or applicant for registration in accordance with the rules and regulations promulgated under § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-41"><span class="s2056859DefaultParagraphFont">34-20B-41</span></a><span class="s2056859DefaultParagraphFont">.</span></p><p dir="ltr" class="s2056859Normal"><span xml:space="preserve" class="s2056859000001"> </span></p><p dir="ltr" class="s2056859Normal"><span class="s2056859SCL">Source:</span><span xml:space="preserve" class="s2056859SCL-000002"> SL 1970, ch 229, § 9 (e); SDCL Supp, § 39-17-86.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056860Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056860SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056860CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056860Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056860DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056860000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056860SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056860SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056860Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-41"><span class="s2056860SENU">34-20B-41</span></a><span xml:space="preserve" class="s2056860SENU">. </span><span class="s2056860CL">Promulgation of rules by department--Fees.</span></p><p dir="ltr" class="s2056860Normal-000000"><span xml:space="preserve" class="s2056860DefaultParagraphFont">The department may promulgate rules pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=1-26"><span class="s2056860DefaultParagraphFont">1-26</span></a><span xml:space="preserve" class="s2056860DefaultParagraphFont"> relating to exclusions from uniform drug articles pursuant to subdivision 34-20B-2(1); the definition of precursors; exceptions from Schedule III of stimulants, depressants, and anabolic steroid-estrogen combinations in medicinal preparations; the registration of manufacturers, distributors, and dispensers; waivers of registration; the suspending, revoking, surrendering, transferring, and reinstating of registration; inventories and records of controlled substances establishing minimum standards for prescribing and dispensing practices, labeling and security requirements and the issuance of prescriptions as provided by this chapter and chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=22-42"><span class="s2056860DefaultParagraphFont">22-42</span></a><span class="s2056860DefaultParagraphFont">; and the inspection of registered premises. The department may charge reasonable fees relating to the registration and control of the manufacture, distribution, and dispensing of controlled drugs and substances within this state. No fee may exceed one hundred fifty dollars.</span></p><p dir="ltr" class="s2056860Normal"><span xml:space="preserve" class="s2056860000001"> </span></p><p dir="ltr" class="s2056860Normal"><span class="s2056860SCL">Source:</span><span xml:space="preserve" class="s2056860SCL-000002"> SL 1970, ch 229, §§ 9, 14; SDCL Supp, § 39-17-87; SL 1980, ch 238, § 2; SL 1993, ch 247, § 8; SL 2004, ch 232, § 1; SL 2009, ch 164, § 4.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056861Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056861SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056861CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056861Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056861DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056861000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056861SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056861SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056861Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-42"><span class="s2056861SENU">34-20B-42</span></a><span xml:space="preserve" class="s2056861SENU">. </span><span class="s2056861CL">Unauthorized manufacture or distribution by registrant prohibited--Civil fine--Knowing violation as felony.</span></p><p dir="ltr" class="s2056861Normal-000000"><span class="s2056861DefaultParagraphFont">No person who is a registrant shall manufacture, distribute, or dispense a controlled drug or substance not authorized by his registration to another registrant or other authorized person. A violation of this section may be punished by a civil fine of not more than ten thousand dollars. In addition, if the violation was done knowingly, it is a Class 5 felony.</span></p><p dir="ltr" class="s2056861Normal"><span xml:space="preserve" class="s2056861000001"> </span></p><p dir="ltr" class="s2056861Normal"><span class="s2056861SCL">Source:</span><span xml:space="preserve" class="s2056861SCL-000002"> SL 1970, ch 229, § 10 (d) (2); SDCL Supp, § 39-17-98; SL 1977, ch 190, § 397.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-42.1 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-42.1 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-42.1"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-42.1, 34-20B-42.2. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1992, ch 245, &#167;&#167;&nbsp;7, 8.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056863Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056863SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056863CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056863Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056863DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056863000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056863SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056863SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056863Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-43"><span class="s2056863SENU">34-20B-43</span></a><span xml:space="preserve" class="s2056863SENU">. </span><span class="s2056863CL">Omission or removal of required symbol prohibited--Civil fine--Knowing violation as misdemeanor.</span></p><p dir="ltr" class="s2056863Normal-000000"><span class="s2056863DefaultParagraphFont">No person shall omit, remove, alter, or obliterate a symbol required by this chapter. A violation of this section may be punished by a civil fine of not more than ten thousand dollars. In addition, if the violation was done knowingly, it is a Class 1 misdemeanor.</span></p><p dir="ltr" class="s2056863Normal"><span xml:space="preserve" class="s2056863000001"> </span></p><p dir="ltr" class="s2056863Normal"><span class="s2056863SCL">Source:</span><span xml:space="preserve" class="s2056863SCL-000002"> SL 1970, ch 229, § 10 (d) (3); SDCL Supp, § 39-17-99; SL 1976, ch 158, § 42-18; SL 1977, ch 190, § 398.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056864Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056864SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056864CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056864Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056864DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056864000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056864SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056864SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056864Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-44"><span class="s2056864SENU">34-20B-44</span></a><span xml:space="preserve" class="s2056864SENU">. </span><span class="s2056864CL">Failure to keep or furnish required record or report prohibited--Civil fine--Knowing violation as felony.</span></p><p dir="ltr" class="s2056864Normal-000000"><span class="s2056864DefaultParagraphFont">No person shall refuse or fail to make, keep, or furnish any record, report, notification, order form, statement, invoice, or information required under this chapter. A violation of this section may be punished by a civil fine of not more than ten thousand dollars. In addition, if the violation was done knowingly, it is a Class 6 felony.</span></p><p dir="ltr" class="s2056864Normal"><span xml:space="preserve" class="s2056864000001"> </span></p><p dir="ltr" class="s2056864Normal"><span class="s2056864SCL">Source:</span><span xml:space="preserve" class="s2056864SCL-000002"> SL 1970, ch 229, § 10 (d) (4); SDCL Supp, § 39-17-100; SL 1977, ch 190, § 399.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056865Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056865SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056865CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056865Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056865DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056865000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056865SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056865SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056865Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-45"><span class="s2056865SENU">34-20B-45</span></a><span xml:space="preserve" class="s2056865SENU">. </span><span class="s2056865CL">Civil fine for violation by manufacturer or distributor--Knowing violation as felony.</span></p><p dir="ltr" class="s2056865Normal-000000"><span xml:space="preserve" class="s2056865DefaultParagraphFont">Any person who violates any of §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-42"><span class="s2056865DefaultParagraphFont">34-20B-42</span></a><span xml:space="preserve" class="s2056865DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-44"><span class="s2056865DefaultParagraphFont">34-20B-44</span></a><span class="s2056865DefaultParagraphFont">, inclusive, is punishable by a civil fine of not more than ten thousand dollars. In addition, if the violation is prosecuted by an information or indictment which alleges that the violation was committed knowingly and the trier of fact specifically finds that the violation was committed knowingly such person is guilty of a Class 5 felony.</span></p><p dir="ltr" class="s2056865Normal"><span xml:space="preserve" class="s2056865000001"> </span></p><p dir="ltr" class="s2056865Normal"><span class="s2056865SCL">Source:</span><span xml:space="preserve" class="s2056865SCL-000002"> SL 1970, ch 229, § 10 (d) (7); SDCL Supp, § 39-17-103; SL 1977, ch 189, § 119.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056866Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056866SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056866CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056866Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056866DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056866000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056866SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056866SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056866Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-46"><span class="s2056866SENU">34-20B-46</span></a><span xml:space="preserve" class="s2056866SENU">. </span><span class="s2056866CL">Intentional distribution of Schedule I or II substance without order form as felony.</span></p><p dir="ltr" class="s2056866Normal-000000"><span class="s2056866DefaultParagraphFont">It is a Class 5 felony for any person who is a registrant knowingly to distribute a controlled drug or substance classified in Schedules I or II, in the course of his legitimate business, except pursuant to an order form as required by this chapter.</span></p><p dir="ltr" class="s2056866Normal"><span xml:space="preserve" class="s2056866000001"> </span></p><p dir="ltr" class="s2056866Normal"><span class="s2056866SCL">Source:</span><span xml:space="preserve" class="s2056866SCL-000002"> SL 1970, ch 229, § 10 (e) (1); SDCL Supp, § 39-17-104; SL 1977, ch 189, § 120; SL 1977, ch 190, § 403.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056867Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056867SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056867CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056867Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056867DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056867000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056867SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056867SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056867Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-47"><span class="s2056867SENU">34-20B-47</span></a><span xml:space="preserve" class="s2056867SENU">. </span><span class="s2056867CL">Intentional use of unauthorized registration number as felony.</span></p><p dir="ltr" class="s2056867Normal-000000"><span class="s2056867DefaultParagraphFont">It is a Class 5 felony for any person knowingly to use in the course of the manufacture or distribution of a controlled drug or substance a registration number which is fictitious, revoked, suspended, or issued to another person.</span></p><p dir="ltr" class="s2056867Normal"><span xml:space="preserve" class="s2056867000001"> </span></p><p dir="ltr" class="s2056867Normal"><span class="s2056867SCL">Source:</span><span xml:space="preserve" class="s2056867SCL-000002"> SL 1970, ch 229, § 10 (e) (2); SDCL Supp, § 39-17-105; SL 1977, ch 189, § 121; SL 1977, ch 190, § 404.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056868Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056868SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056868CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056868Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056868DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056868000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056868SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056868SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056868Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-48"><span class="s2056868SENU">34-20B-48</span></a><span xml:space="preserve" class="s2056868SENU">. </span><span class="s2056868CL">Intentional falsification or omission of material information as felony.</span></p><p dir="ltr" class="s2056868Normal-000000"><span class="s2056868DefaultParagraphFont">It is a Class 5 felony for any person knowingly to furnish false or fraudulent material information in, or omit any material information from, any application, report, or other document required to be kept or filed under this chapter, or any record required to be kept by this chapter.</span></p><p dir="ltr" class="s2056868Normal"><span xml:space="preserve" class="s2056868000001"> </span></p><p dir="ltr" class="s2056868Normal"><span class="s2056868SCL">Source:</span><span xml:space="preserve" class="s2056868SCL-000002"> SL 1970, ch 229, § 10 (e) (4); SDCL Supp, § 39-17-107; SL 1977, ch 189, § 122; SL 1977, ch 190, § 406.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056869Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056869SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056869CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056869Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056869DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056869000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056869SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056869SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056869Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-49"><span class="s2056869SENU">34-20B-49</span></a><span xml:space="preserve" class="s2056869SENU">. </span><span class="s2056869CL">Criminal penalties in addition to civil and administrative penalties.</span></p><p dir="ltr" class="s2056869Normal-000000"><span xml:space="preserve" class="s2056869DefaultParagraphFont">Any penalty imposed for violation of §§ </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-42"><span class="s2056869DefaultParagraphFont">34-20B-42</span></a><span xml:space="preserve" class="s2056869DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-48"><span class="s2056869DefaultParagraphFont">34-20B-48</span></a><span class="s2056869DefaultParagraphFont">, inclusive, shall be in addition to, and not in lieu of, any civil or administrative penalty or sanction authorized by law.</span></p><p dir="ltr" class="s2056869Normal"><span xml:space="preserve" class="s2056869000001"> </span></p><p dir="ltr" class="s2056869Normal"><span class="s2056869SCL">Source:</span><span xml:space="preserve" class="s2056869SCL-000002"> SL 1970, ch 229, § 10 (g); SDCL Supp, § 39-17-112; SL 1977, ch 189, § 123.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-50 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-50 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-50"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-50. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1997, ch 203, &#167;&nbsp;1.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056871Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056871SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056871CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056871Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056871DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056871000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056871SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056871SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056871Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-51"><span class="s2056871SENU">34-20B-51</span></a><span xml:space="preserve" class="s2056871SENU">. </span><span class="s2056871CL">Survival of right of action.</span></p><p dir="ltr" class="s2056871Normal-000000"><span xml:space="preserve" class="s2056871DefaultParagraphFont">In case of the death of either party, the right of action given in chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20C"><span class="s2056871DefaultParagraphFont">34-20C</span></a><span xml:space="preserve" class="s2056871DefaultParagraphFont"> shall survive to or against such party's personal representative.</span></p><p dir="ltr" class="s2056871Normal"><span xml:space="preserve" class="s2056871000001"> </span></p><p dir="ltr" class="s2056871Normal"><span class="s2056871SCL">Source:</span><span xml:space="preserve" class="s2056871SCL-000002"> SL 1977, ch 316; SL 1997, ch 203, § 15.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056872Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056872SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056872CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056872Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056872DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056872000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056872SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056872SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056872Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-52"><span class="s2056872SENU">34-20B-52</span></a><span xml:space="preserve" class="s2056872SENU">. </span><span class="s2056872CL">Civil action for recovery from unlawful distributor--Limitation of actions.</span></p><p dir="ltr" class="s2056872Normal-000000"><span xml:space="preserve" class="s2056872DefaultParagraphFont">All suits for damages under chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20C"><span class="s2056872DefaultParagraphFont">34-20C</span></a><span xml:space="preserve" class="s2056872DefaultParagraphFont"> shall be by civil action in any court of this state having jurisdiction thereof, which shall be commenced within two years of the date on which the injury was incurred.</span></p><p dir="ltr" class="s2056872Normal"><span xml:space="preserve" class="s2056872000001"> </span></p><p dir="ltr" class="s2056872Normal"><span class="s2056872SCL">Source:</span><span xml:space="preserve" class="s2056872SCL-000002"> SL 1977, ch 316; SL 1997, ch 203, § 21.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056873Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056873SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056873CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056873Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056873DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056873000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056873SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056873SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056873Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-53"><span class="s2056873SENU">34-20B-53</span></a><span xml:space="preserve" class="s2056873SENU">. </span><span class="s2056873CL">Minor's recovery payable to parent or conservator.</span></p><p dir="ltr" class="s2056873Normal-000000"><span xml:space="preserve" class="s2056873DefaultParagraphFont">All damages recovered by a minor under chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20C"><span class="s2056873DefaultParagraphFont">34-20C</span></a><span xml:space="preserve" class="s2056873DefaultParagraphFont"> shall be paid to such minor or to the minor's parent or conservator as the court directs.</span></p><p dir="ltr" class="s2056873Normal"><span xml:space="preserve" class="s2056873000001"> </span></p><p dir="ltr" class="s2056873Normal"><span class="s2056873SCL">Source:</span><span xml:space="preserve" class="s2056873SCL-000002"> SL 1977, ch 316; SL 1993, ch 213, § 228; SL 1997, ch 203, § 20.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056874Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056874SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056874CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056874Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056874DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056874000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056874SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056874SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056874Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-54"><span class="s2056874SENU">34-20B-54</span></a><span xml:space="preserve" class="s2056874SENU">. </span><span class="s2056874CL">Cooperation by department with federal and state agencies.</span></p><p dir="ltr" class="s2056874Normal-000000"><span class="s2056874DefaultParagraphFont">The Department of Health shall, in addition to other powers and duties vested in it by this chapter or any other act, cooperate with federal and other state agencies in discharging its responsibilities concerning traffic in drugs and substances.</span></p><p dir="ltr" class="s2056874Normal"><span xml:space="preserve" class="s2056874000001"> </span></p><p dir="ltr" class="s2056874Normal"><span class="s2056874SCL">Source:</span><span xml:space="preserve" class="s2056874SCL-000002"> SL 1970, ch 229, § 5 (a); SDCL Supp, § 39-17-115.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056875Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056875SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056875CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056875Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056875DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056875000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056875SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056875SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056875Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-55"><span class="s2056875SENU">34-20B-55</span></a><span xml:space="preserve" class="s2056875SENU">. </span><span class="s2056875CL">Centralized statistical unit--Availability of information.</span></p><p dir="ltr" class="s2056875Normal-000000"><span class="s2056875DefaultParagraphFont">The Department of Health shall cooperate with the federal drug enforcement administration by establishing a centralized unit which shall accept, catalogue, file, and collect statistics, and make such information available for federal, state, and local law enforcement purposes.</span></p><p dir="ltr" class="s2056875Normal"><span xml:space="preserve" class="s2056875000001"> </span></p><p dir="ltr" class="s2056875Normal"><span class="s2056875SCL">Source:</span><span xml:space="preserve" class="s2056875SCL-000002"> SL 1970, ch 229, § 5 (d); SDCL Supp, § 39-17-116; SL 1977, ch 190, § 412; SL 1989, ch 293, § 6.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056876Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056876SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056876CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056876Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056876DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056876000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056876SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056876SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056876Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-56"><span class="s2056876SENU">34-20B-56</span></a><span xml:space="preserve" class="s2056876SENU">. </span><span class="s2056876CL">State agencies to cooperate with department.</span></p><p dir="ltr" class="s2056876Normal-000000"><span class="s2056876DefaultParagraphFont">It shall be the duty of all departments, officers, agencies, and employees of the State of South Dakota to cooperate with the Department of Health in carrying out its functions under this chapter or any other act.</span></p><p dir="ltr" class="s2056876Normal"><span xml:space="preserve" class="s2056876000001"> </span></p><p dir="ltr" class="s2056876Normal"><span class="s2056876SCL">Source:</span><span xml:space="preserve" class="s2056876SCL-000002"> SL 1970, ch 229, § 4; SDCL Supp, § 39-17-117.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056877Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056877SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056877CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056877Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056877DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056877000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056877SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056877SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056877Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-57"><span class="s2056877SENU">34-20B-57</span></a><span xml:space="preserve" class="s2056877SENU">. </span><span class="s2056877CL">Exchange of information between governmental officials.</span></p><p dir="ltr" class="s2056877Normal-000000"><span class="s2056877DefaultParagraphFont">The Department of Health shall, in addition to other powers and duties vested in it by this chapter or any other act, arrange for the exchange of information between governmental officials concerning the use and abuse of drugs and substances.</span></p><p dir="ltr" class="s2056877Normal"><span xml:space="preserve" class="s2056877000001"> </span></p><p dir="ltr" class="s2056877Normal"><span class="s2056877SCL">Source:</span><span xml:space="preserve" class="s2056877SCL-000002"> SL 1970, ch 229, § 5 (b); SDCL Supp, § 39-17-118.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056878Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056878SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056878CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056878Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056878DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056878000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056878SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056878SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056878Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-58"><span class="s2056878SENU">34-20B-58</span></a><span xml:space="preserve" class="s2056878SENU">. </span><span class="s2056878CL">County and municipal funds authorized.</span></p><p dir="ltr" class="s2056878Normal-000000"><span class="s2056878DefaultParagraphFont">The governing bodies of the several counties and municipalities in the state are hereby authorized to establish funds and make appropriations thereto for the purpose of enforcing the provisions of this chapter.</span></p><p dir="ltr" class="s2056878Normal"><span xml:space="preserve" class="s2056878000001"> </span></p><p dir="ltr" class="s2056878Normal"><span class="s2056878SCL">Source:</span><span xml:space="preserve" class="s2056878SCL-000002"> SL 1970, ch 229, § 13; SDCL Supp, § 39-17-119.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056879Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056879SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056879CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056879Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056879DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056879000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056879SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056879SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056879Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-59"><span class="s2056879SENU">34-20B-59</span></a><span xml:space="preserve" class="s2056879SENU">. </span><span class="s2056879CL">Use of county and municipal funds to make illegal purchases.</span></p><p dir="ltr" class="s2056879Normal-000000"><span xml:space="preserve" class="s2056879DefaultParagraphFont">Funds established pursuant to § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-58"><span class="s2056879DefaultParagraphFont">34-20B-58</span></a><span xml:space="preserve" class="s2056879DefaultParagraphFont"> may be expended confidentially for the purpose of making purchases and acquisitions of drugs and substances which are illegal under this chapter, when such purchases are necessary to obtaining convictions under this chapter.</span></p><p dir="ltr" class="s2056879Normal"><span xml:space="preserve" class="s2056879000001"> </span></p><p dir="ltr" class="s2056879Normal"><span class="s2056879SCL">Source:</span><span xml:space="preserve" class="s2056879SCL-000002"> SL 1970, ch 229, § 13 (a); SDCL Supp, § 39-17-120.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056880Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056880SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056880CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056880Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056880DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056880000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056880SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056880SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056880Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-60"><span class="s2056880SENU">34-20B-60</span></a><span xml:space="preserve" class="s2056880SENU">. </span><span class="s2056880CL">Use of county and municipal funds to employ special agents.</span></p><p dir="ltr" class="s2056880Normal-000000"><span xml:space="preserve" class="s2056880DefaultParagraphFont">Funds established pursuant to § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-58"><span class="s2056880DefaultParagraphFont">34-20B-58</span></a><span xml:space="preserve" class="s2056880DefaultParagraphFont"> may further be expended confidentially to employ special agents, pay their salaries and expenses, for the purpose of providing undercover assistance to local law enforcement officials in gathering evidence of violations of this chapter, making arrests thereunder, and obtaining convictions.</span></p><p dir="ltr" class="s2056880Normal"><span xml:space="preserve" class="s2056880000001"> </span></p><p dir="ltr" class="s2056880Normal"><span class="s2056880SCL">Source:</span><span xml:space="preserve" class="s2056880SCL-000002"> SL 1970, ch 229, § 13 (b); SDCL Supp, § 39-17-121.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056881Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056881SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056881CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056881Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056881DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056881000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056881SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056881SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056881Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-61"><span class="s2056881SENU">34-20B-61</span></a><span xml:space="preserve" class="s2056881SENU">. </span><span class="s2056881CL">Law enforcement and cooperation by Division of Criminal Investigation and state's attorneys.</span></p><p dir="ltr" class="s2056881Normal-000000"><span class="s2056881DefaultParagraphFont">It is hereby made the duty of the Division of Criminal Investigation, its officers, agents, inspectors, and representatives, and of all state's attorneys, to enforce all provisions of this chapter, except those specifically delegated, and to cooperate with all agencies charged with the enforcement of the laws of the United States, of this state, and of all other states, relating to controlled drugs and substances.</span></p><p dir="ltr" class="s2056881Normal"><span xml:space="preserve" class="s2056881000001"> </span></p><p dir="ltr" class="s2056881Normal"><span class="s2056881SCL">Source:</span><span xml:space="preserve" class="s2056881SCL-000002"> SL 1970, ch 229, § 11 (a); SDCL Supp, § 39-17-122.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056882Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056882SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056882CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056882Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056882DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056882000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056882SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056882SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056882Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-62"><span class="s2056882SENU">34-20B-62</span></a><span xml:space="preserve" class="s2056882SENU">. </span><span class="s2056882CL">Attorney general to enforce chapter.</span></p><p dir="ltr" class="s2056882Normal-000000"><span class="s2056882DefaultParagraphFont">The Office of the Attorney General shall retain authority for all prosecutions and other actions at law in the enforcement of this chapter.</span></p><p dir="ltr" class="s2056882Normal"><span xml:space="preserve" class="s2056882000001"> </span></p><p dir="ltr" class="s2056882Normal"><span class="s2056882SCL">Source:</span><span xml:space="preserve" class="s2056882SCL-000002"> SL 1974, ch 261, § 8; SDCL Supp, § 39-17-122.1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056883Normal { text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056883SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056883CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056883Normal-000000 { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056883DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2056883Normal-000001 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2056883000002 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056883SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056883SCL-000003 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056883Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-63"><span class="s2056883SENU">34-20B-63</span></a><span xml:space="preserve" class="s2056883SENU">. </span><span class="s2056883CL">Special powers of agents of Division of Criminal Investigation.</span></p><p dir="ltr" class="s2056883Normal-000000"><span class="s2056883DefaultParagraphFont">Any officer or employee of the Division of Criminal Investigation designated by the attorney general may:</span></p><p dir="ltr" class="s2056883Normal-000001"><span class="s2056883DefaultParagraphFont">(1)    Carry firearms;</span></p><p dir="ltr" class="s2056883Normal-000001"><span class="s2056883DefaultParagraphFont">(2)    Execute and serve search warrants, arrest warrants, administrative inspection warrants, subpoenas, and summonses issued under the authority of this state;</span></p><p dir="ltr" class="s2056883Normal-000001"><span class="s2056883DefaultParagraphFont">(3)    Make arrests without warrant for any offense under this chapter committed in his presence, or if he has probable cause to believe that the person to be arrested has committed or is committing a felony;</span></p><p dir="ltr" class="s2056883Normal-000001"><span class="s2056883DefaultParagraphFont">(4)    Make seizures of property pursuant to the provisions of this chapter; and</span></p><p dir="ltr" class="s2056883Normal-000001"><span class="s2056883DefaultParagraphFont">(5)    Perform such other law enforcement duties as the chief agent may designate.</span></p><p dir="ltr" class="s2056883Normal"><span xml:space="preserve" class="s2056883000002"> </span></p><p dir="ltr" class="s2056883Normal"><span class="s2056883SCL">Source:</span><span xml:space="preserve" class="s2056883SCL-000003"> SL 1970, ch 229, § 11 (b); SDCL Supp, § 39-17-123.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056884Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056884SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056884CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056884Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056884DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056884000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056884SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056884SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056884Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-64"><span class="s2056884SENU">34-20B-64</span></a><span xml:space="preserve" class="s2056884SENU">. </span><span class="s2056884CL">Drug control fund created--Administration by attorney general--Expenditures--Excess funds.</span></p><p dir="ltr" class="s2056884Normal-000000"><span class="s2056884DefaultParagraphFont">There is hereby created in the state treasury a special revolving fund to be known as the "drug control fund," which shall be administered by the attorney general. The attorney general may authorize expenditure of moneys in the fund for purchase of controlled drugs and substances, as defined in this chapter, by authorized agents of the attorney general from unregistered dispensers and distributors. All disbursements from the fund shall be made on warrants drawn by the state auditor on vouchers approved by the attorney general. Any moneys in the fund in excess of two hundred fifty thousand dollars shall be available for distribution by the attorney general. Upon application by any local law enforcement agency, any drug law enforcement task force or the division of highway patrol, the attorney general may authorize release of any such available moneys in the fund for the purpose of assisting local law enforcement agencies in drug control and drug offender apprehension efforts.</span></p><p dir="ltr" class="s2056884Normal"><span xml:space="preserve" class="s2056884000001"> </span></p><p dir="ltr" class="s2056884Normal"><span class="s2056884SCL">Source:</span><span xml:space="preserve" class="s2056884SCL-000002"> SL 1976, ch 5, §§ 1 to 3; SDCL Supp, § 39-17-123.1; SL 1990, ch 271.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-65 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-65 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-65"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-65, 34-20B-66. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1978, ch 178, &#167;&nbsp;577.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056886Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056886SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056886CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056886Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056886DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056886000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056886SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056886SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056886Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-67"><span class="s2056886SENU">34-20B-67</span></a><span xml:space="preserve" class="s2056886SENU">. </span><span class="s2056886CL">Peace officers to cooperate with Division of Criminal Investigation.</span></p><p dir="ltr" class="s2056886Normal-000000"><span class="s2056886DefaultParagraphFont">It is hereby made the duty of all peace officers within the state to cooperate with the Division of Criminal Investigation, its officers, agents, inspectors, and representatives, and to carry out all lawful orders issued by the Division of Criminal Investigation, its officers, agents, inspectors, and representatives, relating to controlled drugs and substances.</span></p><p dir="ltr" class="s2056886Normal"><span xml:space="preserve" class="s2056886000001"> </span></p><p dir="ltr" class="s2056886Normal"><span class="s2056886SCL">Source:</span><span xml:space="preserve" class="s2056886SCL-000002"> SL 1970, ch 229, § 11 (a) (1); SDCL Supp, § 39-17-126.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056887Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056887SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056887CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056887Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056887DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056887000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056887SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056887SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056887Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-68"><span class="s2056887SENU">34-20B-68</span></a><span xml:space="preserve" class="s2056887SENU">. </span><span class="s2056887CL">Trial court jurisdiction to enjoin violations.</span></p><p dir="ltr" class="s2056887Normal-000000"><span class="s2056887DefaultParagraphFont">The trial courts of the state shall have jurisdiction in proceedings in accordance with the rules of these courts to enjoin violations of this chapter.</span></p><p dir="ltr" class="s2056887Normal"><span xml:space="preserve" class="s2056887000001"> </span></p><p dir="ltr" class="s2056887Normal"><span class="s2056887SCL">Source:</span><span xml:space="preserve" class="s2056887SCL-000002"> SL 1970, ch 229, § 11 (d) (1); SDCL Supp, § 39-17-127.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056888Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056888SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056888CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056888Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056888DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056888000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056888SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056888SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056888Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-69"><span class="s2056888SENU">34-20B-69</span></a><span xml:space="preserve" class="s2056888SENU">. </span><span class="s2056888CL">Jury trial of violations of injunction.</span></p><p dir="ltr" class="s2056888Normal-000000"><span xml:space="preserve" class="s2056888DefaultParagraphFont">In case of an alleged violation of an injunction or restraining order issued under § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-68"><span class="s2056888DefaultParagraphFont">34-20B-68</span></a><span class="s2056888DefaultParagraphFont">, trial shall, upon demand of the accused, be by jury in accordance with the rules of the state courts.</span></p><p dir="ltr" class="s2056888Normal"><span xml:space="preserve" class="s2056888000001"> </span></p><p dir="ltr" class="s2056888Normal"><span class="s2056888SCL">Source:</span><span xml:space="preserve" class="s2056888SCL-000002"> SL 1970, ch 229, § 11 (d) (2); SDCL Supp, § 39-17-128.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s2083330Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2083330SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2083330CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2083330Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2083330DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2083330StatuteNumber1 { margin-left: 0.70in; text-indent: -0.45in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2083330Statute-000000 { text-indent: 0.25in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2083330000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2083330NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2083330DefaultParagraphFont-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2083330SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-70 - Property subject to forfeiture."><meta property="og:description" content="SDLRC Codified Law 34-20B-70 - Property subject to forfeiture."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes?Statute=34-20B-70"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s2083330Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-70" rel="noopener"><span class="s2083330SENU">34-20B-70</span></a><span xml:space="preserve" class="s2083330SENU">. </span><span xml:space="preserve" class="s2083330CL">Property subject to forfeiture. </span></p><p dir="ltr" class="s2083330Statute"><span xml:space="preserve" class="s2083330DefaultParagraphFont">The following are subject to forfeiture pursuant to chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=23A-49" rel="noopener"><span class="s2083330DefaultParagraphFont">23A-49</span></a><span xml:space="preserve" class="s2083330DefaultParagraphFont"> and no property right exists in them:</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span xml:space="preserve" class="s2083330DefaultParagraphFont">(1)    All controlled drugs and substances and marijuana which have been manufactured, distributed, dispensed, or acquired in violation of the provisions of this chapter or chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=22-42" rel="noopener"><span class="s2083330DefaultParagraphFont">22-42</span></a><span class="s2083330DefaultParagraphFont">;</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span xml:space="preserve" class="s2083330DefaultParagraphFont">(2)    All raw materials, products, and equipment of any kind which are used or intended for use, in manufacturing, compounding, or processing any controlled drug or substance or marijuana in excess of one-half pound in violation of the provisions of this chapter or chapter </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=22-42" rel="noopener"><span class="s2083330DefaultParagraphFont">22-42</span></a><span class="s2083330DefaultParagraphFont">;</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span class="s2083330DefaultParagraphFont">(3)    All property which is used, or intended for use, as a container for property described in subdivisions (1) and (2);</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span class="s2083330DefaultParagraphFont">(4)    All conveyances including aircraft, vehicles, or vessels, which are used, or intended for use, to facilitate the unlawful distribution or possession with the intent to distribute marijuana in excess of one-half pound or any quantity of any other property described in subdivision (1) or (2);</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span class="s2083330DefaultParagraphFont">(5)    All books, records, and research, including formulas, microfilm, tapes, and data which are used, or intended for use, in violation of this chapter;</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span class="s2083330DefaultParagraphFont">(6)    Any funds or other things of value used for the purposes of unlawfully purchasing, attempting to purchase, distributing, or attempting to distribute any controlled drug or substance in an amount intended for distribution and not for personal use, and marijuana in excess of one-half pound; or</span></p><p dir="ltr" class="s2083330StatuteNumber1"><span class="s2083330DefaultParagraphFont">(7)    Any assets, interest, profits, income, and proceeds acquired or derived from the unlawful purchase, attempted purchase, distribution, or attempted distribution of any controlled drug or substance in an amount intended for distribution and not for personal use, and marijuana in excess of one-half pound.</span></p><p dir="ltr" class="s2083330Statute-000000"><span xml:space="preserve" class="s2083330DefaultParagraphFont">Property described in subdivision (1) shall be deemed contraband and shall be summarily forfeited to the state, property described in subdivisions (2), (3), (5), (6), and (7) is subject to forfeiture under the terms of § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=23A-49-14" rel="noopener"><span class="s2083330DefaultParagraphFont">23A-49-14</span></a><span xml:space="preserve" class="s2083330DefaultParagraphFont">, and property described in subdivision (4) is subject to forfeiture under the terms of § </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=23A-49-15" rel="noopener"><span class="s2083330DefaultParagraphFont">23A-49-15</span></a><span class="s2083330DefaultParagraphFont">.</span></p><p dir="ltr" class="s2083330Normal"><span xml:space="preserve" class="s2083330000001"> </span></p><p dir="ltr" class="s2083330NoIndent"><span xml:space="preserve" class="s2083330DefaultParagraphFont-000002">Source: </span><span class="s2083330SCL">SL 1970, ch 229, § 11 (e) (1); SDCL Supp, § 39-17-129; SL 1976, ch 158, §§ 42-19, 42-20; SL 1977, ch 189, §§ 125, 126; SL 1977, ch 317, §§ 1 to 3; SL 1982, ch 262, § 2; SL 1983, ch 255; SL 1985, ch 279, § 1; SL 2016, ch 138, § 21; SL 2021, ch 145, § 1.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-70.1 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-70.1 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-70.1"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-70.1 to 34-20B-80. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 2016, ch 138, &#167;&#167;&nbsp;23 to 33.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056891Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056891SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056891CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056891Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056891DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056891000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056891SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056891SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056891Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-81"><span class="s2056891SENU">34-20B-81</span></a><span xml:space="preserve" class="s2056891SENU">. </span><span class="s2056891CL">Unlawful substances deemed contraband--Summary forfeiture.</span></p><p dir="ltr" class="s2056891Normal-000000"><span class="s2056891DefaultParagraphFont">All property described in subdivision 34-20B-70(1) shall be deemed contraband and shall be summarily forfeited to the state. Controlled substances or marijuana which are seized or come into possession of the state, the owners of which are unknown, shall be deemed contraband and shall be summarily forfeited to the state.</span></p><p dir="ltr" class="s2056891Normal"><span xml:space="preserve" class="s2056891000001"> </span></p><p dir="ltr" class="s2056891Normal"><span class="s2056891SCL">Source:</span><span xml:space="preserve" class="s2056891SCL-000002"> SL 1977, ch 317, § 6.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056892Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056892SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056892CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056892Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056892DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056892000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056892SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056892SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056892Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-82"><span class="s2056892SENU">34-20B-82</span></a><span xml:space="preserve" class="s2056892SENU">. </span><span class="s2056892CL">Unauthorized Schedule I substances deemed contraband--Summary seizure and forfeiture.</span></p><p dir="ltr" class="s2056892Normal-000000"><span class="s2056892DefaultParagraphFont">All substances listed in Schedule I that are possessed, transferred, sold, or offered for sale in violation of the provisions of this chapter shall be deemed contraband and seized and summarily forfeited to the state. Similarly, all substances listed in Schedule I, which are seized or come into the possession of the state, the owners of which are unknown, shall be deemed contraband and summarily forfeited to the state.</span></p><p dir="ltr" class="s2056892Normal"><span xml:space="preserve" class="s2056892000001"> </span></p><p dir="ltr" class="s2056892Normal"><span class="s2056892SCL">Source:</span><span xml:space="preserve" class="s2056892SCL-000002"> SL 1970, ch 229, § 11 (e) (5); SDCL Supp, § 39-17-138.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056893Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056893SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056893CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056893Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056893DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056893000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056893SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056893SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056893Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-83"><span class="s2056893SENU">34-20B-83</span></a><span xml:space="preserve" class="s2056893SENU">. </span><span class="s2056893CL">Seizure and summary forfeiture of plant precursors of Schedule I and II substances--Failure to produce registration as authority.</span></p><p dir="ltr" class="s2056893Normal-000000"><span class="s2056893DefaultParagraphFont">All species of plants from which controlled substances in Schedules I and II may be derived which have been planted or cultivated in violation of this chapter, or of which the owners or cultivators are unknown, or which are wild growths, may be seized and summarily forfeited to the state. The failure, upon demand by the chief agent or any peace officer at his direction, of the person in occupancy or in control of land or premises upon which such species of plants are growing or being stored, to produce an appropriate registration, or proof that he is the holder thereof, shall constitute authority for the seizure and forfeiture.</span></p><p dir="ltr" class="s2056893Normal"><span xml:space="preserve" class="s2056893000001"> </span></p><p dir="ltr" class="s2056893Normal"><span class="s2056893SCL">Source:</span><span xml:space="preserve" class="s2056893SCL-000002"> SL 1970, ch 229, § 11 (e) (6); SDCL Supp, § 39-17-139.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-84 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-84 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-84"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-84 to 34-20B-89. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 2016, ch 138, &#167;&#167;&nbsp;34 to 39.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056895Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056895SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056895CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056895Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056895DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056895000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056895SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056895SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056895Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-90"><span class="s2056895SENU">34-20B-90</span></a><span xml:space="preserve" class="s2056895SENU">. </span><span class="s2056895CL">Burden of proof as to registration or order form.</span></p><p dir="ltr" class="s2056895Normal-000000"><span class="s2056895DefaultParagraphFont">In the absence of proof that a person is the duly authorized holder of an appropriate registration or order form issued under this chapter, he shall be presumed not to be the holder of such registration or form, and the burden of proof shall be upon him to rebut such presumption.</span></p><p dir="ltr" class="s2056895Normal"><span xml:space="preserve" class="s2056895000001"> </span></p><p dir="ltr" class="s2056895Normal"><span class="s2056895SCL">Source:</span><span xml:space="preserve" class="s2056895SCL-000002"> SL 1970, ch 229, § 11 (f) (2); SDCL Supp, § 39-17-141.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056896Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056896SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056896CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056896Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056896DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056896000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056896SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056896SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056896Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-91"><span class="s2056896SENU">34-20B-91</span></a><span xml:space="preserve" class="s2056896SENU">. </span><span class="s2056896CL">Enforcement officers exempt from liability.</span></p><p dir="ltr" class="s2056896Normal-000000"><span class="s2056896DefaultParagraphFont">No liability shall be imposed by virtue of this chapter upon any duly authorized local, state, or federal officer engaged in the enforcement of this chapter, or who shall be engaged in the enforcement of any law or municipal ordinance relating to controlled drugs and substances.</span></p><p dir="ltr" class="s2056896Normal"><span xml:space="preserve" class="s2056896000001"> </span></p><p dir="ltr" class="s2056896Normal"><span class="s2056896SCL">Source:</span><span xml:space="preserve" class="s2056896SCL-000002"> SL 1970, ch 229, § 11 (f) (3); SDCL Supp, § 39-17-142.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056897Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056897SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056897CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056897Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056897DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056897000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056897SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056897SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056897Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-92"><span class="s2056897SENU">34-20B-92</span></a><span xml:space="preserve" class="s2056897SENU">. </span><span class="s2056897CL">Judicial review of department's decisions--Findings of fact conclusive.</span></p><p dir="ltr" class="s2056897Normal-000000"><span class="s2056897DefaultParagraphFont">All final determinations, findings, and conclusions of the department under this chapter shall be final and conclusive decisions of the matters involved, except that any person aggrieved by such decision may obtain review of the decision in the circuit court. Findings of fact by the department, if supported by substantial evidence, shall be conclusive.</span></p><p dir="ltr" class="s2056897Normal"><span xml:space="preserve" class="s2056897000001"> </span></p><p dir="ltr" class="s2056897Normal"><span class="s2056897SCL">Source:</span><span xml:space="preserve" class="s2056897SCL-000002"> SL 1970, ch 229, § 11 (g); SDCL Supp, § 39-17-143.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-93 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-93 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-93"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-93 to 34-20B-99. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 2016, ch 169, &#167;&#167;&nbsp;23 to 29.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056899Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056899SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056899CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056899Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056899DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056899000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056899SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056899SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056899Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-100"><span class="s2056899SENU">34-20B-100</span></a><span xml:space="preserve" class="s2056899SENU">. </span><span class="s2056899CL">Contracts with government agencies or private organizations.</span></p><p dir="ltr" class="s2056899Normal-000000"><span class="s2056899DefaultParagraphFont">The Department of Health is hereby authorized to contract with agencies of the federal, state, or local government or any private organization or foundation for the purposes of carrying out its functions under this chapter.</span></p><p dir="ltr" class="s2056899Normal"><span xml:space="preserve" class="s2056899000001"> </span></p><p dir="ltr" class="s2056899Normal"><span class="s2056899SCL">Source:</span><span xml:space="preserve" class="s2056899SCL-000002"> SL 1974, ch 263; SDCL Supp, § 39-17-150.1.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-101 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-101 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-101"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-101, 34-20B-102. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 2016, ch 169, &#167;&#167;&nbsp;30, 31.<p> </BODY> </HTML> <br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-103 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-103 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-103"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-103, 34-20B-104. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1985, ch 278, &#167;&nbsp;54.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056902Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056902SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056902CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056902Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056902DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056902000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056902SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056902SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056902Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-105"><span class="s2056902SENU">34-20B-105</span></a><span xml:space="preserve" class="s2056902SENU">. </span><span class="s2056902CL">Residential alcohol and drug abuse treatment program authorized at Human Services Center.</span></p><p dir="ltr" class="s2056902Normal-000000"><span class="s2056902DefaultParagraphFont">The Department of Social Services may establish and operate a residential alcohol and drug abuse treatment program at the South Dakota Human Services Center at Yankton.</span></p><p dir="ltr" class="s2056902Normal"><span xml:space="preserve" class="s2056902000001"> </span></p><p dir="ltr" class="s2056902Normal"><span class="s2056902SCL">Source:</span><span xml:space="preserve" class="s2056902SCL-000002"> SL 1975, ch 255, § 1; SDCL Supp, § 39-17-151.3; SL 1985, ch 278, § 57; SL 1989, ch 21, § 160; SL 2011, ch 1 (Ex. Ord. </span><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=11-1"><span class="s2056902SCL-000002">11-1</span></a><span class="s2056902SCL-000002">), § 163, eff. Apr. 12, 2011.</span></p></div></body></html><br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-106 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-106 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-106"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-106 to 34-20B-109. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1985, ch 278, &#167;&nbsp;54.<p> </BODY> </HTML> <br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-110 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-110 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-110"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-110. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 2016, ch 169, &#167;&nbsp;32.<p> </BODY> </HTML> <br /><hr><br /> <HTML> <HEAD> <HTML> <HEAD> <meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL34-20B-111 </title> <META NAME="Keywords" Content="South Dakota Codified Laws SDCL 34-20B-111 "> <META NAME="Description" Content="South Dakota Codified Laws 34-20B-111"> </HEAD> <BODY> <!-- File converted by Wp2Html Version 4.0 --> <!-- Email Andrew@brackenbeds.co.uk for more details --> <!-- WP Style Open: System_34 --><!-- WP Style End: System_34 --> <Div align="full"> <!-- WP Paired Style On: SENU -->&nbsp;&nbsp;&nbsp;&nbsp;<!-- WP Style End: SENU --> 34-20B-111, 34-20B-112. <!-- WP Paired Style Off: SENU -->&nbsp;<!-- WP Style End: SENU --> Repealed by SL 1985, ch 278, &#167;&nbsp;55.<p> </BODY> </HTML> <br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056906Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056906SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056906CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056906Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056906DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056906000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056906SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056906SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056906Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-113"><span class="s2056906SENU">34-20B-113</span></a><span xml:space="preserve" class="s2056906SENU">. </span><span class="s2056906CL">Severability of provisions and applications.</span></p><p dir="ltr" class="s2056906Normal-000000"><span class="s2056906DefaultParagraphFont">If a provision of this chapter is held unconstitutional or invalid, all constitutional or valid provisions that are severable shall remain in effect. If a provision of this chapter is held unconstitutional or invalid in one or more of its applications, the provision shall remain in effect in all its valid applications that are severable.</span></p><p dir="ltr" class="s2056906Normal"><span xml:space="preserve" class="s2056906000001"> </span></p><p dir="ltr" class="s2056906Normal"><span class="s2056906SCL">Source:</span><span xml:space="preserve" class="s2056906SCL-000002"> SL 1970, ch 229, § 15; SDCL Supp, § 39-17-154.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml"><head><meta charset="UTF-8" /><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML" /><style>span { white-space: pre-wrap; } p.s2056907Normal { margin-top: 0; margin-bottom: 0; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056907SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056907CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2056907Normal-000000 { margin-top: 0; margin-bottom: 0; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-left: 0; margin-right: 0; } span.s2056907DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056907000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } span.s2056907SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2056907SCL-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style></head><body><div><p dir="ltr" class="s2056907Normal"><a href="https://sdlegislature.gov/Statutes/Codified_Laws/DisplayStatute.aspx?Type=Statute&amp;Statute=34-20B-114"><span class="s2056907SENU">34-20B-114</span></a><span xml:space="preserve" class="s2056907SENU">. </span><span class="s2056907CL">Citation of chapter.</span></p><p dir="ltr" class="s2056907Normal-000000"><span class="s2056907DefaultParagraphFont">This chapter may be cited as the State Drugs and Substances Control Act.</span></p><p dir="ltr" class="s2056907Normal"><span xml:space="preserve" class="s2056907000001"> </span></p><p dir="ltr" class="s2056907Normal"><span class="s2056907SCL">Source:</span><span xml:space="preserve" class="s2056907SCL-000002"> SL 1970, ch 229, § 17; SDCL Supp, § 39-17-155.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s11cc7e5753b742e78c72cd52306086e6Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s11cc7e5753b742e78c72cd52306086e6SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s11cc7e5753b742e78c72cd52306086e6CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s11cc7e5753b742e78c72cd52306086e6Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } a.s11cc7e5753b742e78c72cd52306086e6000000 { text-decoration: none; } span.s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s11cc7e5753b742e78c72cd52306086e6StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s11cc7e5753b742e78c72cd52306086e6000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s11cc7e5753b742e78c72cd52306086e6NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s11cc7e5753b742e78c72cd52306086e6SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-115 - Kratom--Facilitating under age use--Penalty."><meta property="og:description" content="SDLRC Codified Law 34-20B-115 - Kratom--Facilitating under age use--Penalty."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-115"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-115" rel="noopener"><span class="s11cc7e5753b742e78c72cd52306086e6SENU">34-20B-115</span></a><span xml:space="preserve" class="s11cc7e5753b742e78c72cd52306086e6SENU">. </span><span class="s11cc7e5753b742e78c72cd52306086e6CL">Kratom--Facilitating under age use--Penalty.</span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6Statute"><a id="_Hlk63840240" class="s11cc7e5753b742e78c72cd52306086e6000000" rel="noopener"></a><span class="s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont">Any of the following actions are unlawful:</span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6StatuteNumber1"><span class="s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont">(1)    To knowingly sell or distribute a kratom product to a person under the age of twenty-one;</span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6StatuteNumber1"><span class="s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont">(2)    The purchase or attempt to purchase, the receipt or attempt to receive, the possession, or the consumption of a kratom product by a person under the age of twenty-one; or</span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6StatuteNumber1"><span class="s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont">(3)    To purchase a kratom product on behalf of, or to give a kratom product to, any person under the age of twenty-one, unless the purchaser is a parent or guardian of the person under the age of twenty-one.</span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6Statute"><span class="s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont">A violation of this section is a Class 2 misdemeanor.</span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6Normal"><span xml:space="preserve" class="s11cc7e5753b742e78c72cd52306086e6000001"> </span></p><p dir="ltr" class="s11cc7e5753b742e78c72cd52306086e6NoIndent"><span xml:space="preserve" class="s11cc7e5753b742e78c72cd52306086e6DefaultParagraphFont-000002">Source: </span><span class="s11cc7e5753b742e78c72cd52306086e6SCL">SL 2021, ch 146, § 1; SL 2025, ch 138, § 2.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s30ad461e44ec40cd81b29b8f0abadf31Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s30ad461e44ec40cd81b29b8f0abadf31SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s30ad461e44ec40cd81b29b8f0abadf31CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s30ad461e44ec40cd81b29b8f0abadf31Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s30ad461e44ec40cd81b29b8f0abadf31000000 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s30ad461e44ec40cd81b29b8f0abadf31NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont-000001 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s30ad461e44ec40cd81b29b8f0abadf31SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-115.1 - Kratom--Prohibited products--Labeling required--Penalty."><meta property="og:description" content="SDLRC Codified Law 34-20B-115.1 - Kratom--Prohibited products--Labeling required--Penalty."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-115.1"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-115.1" rel="noopener"><span class="s30ad461e44ec40cd81b29b8f0abadf31SENU">34-20B-115.1</span></a><span xml:space="preserve" class="s30ad461e44ec40cd81b29b8f0abadf31SENU">. </span><span class="s30ad461e44ec40cd81b29b8f0abadf31CL">Kratom--Prohibited products--Labeling required--Penalty.</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31Statute"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">No person may prepare, sell, or distribute a kratom product that:</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(1)    Contains a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than two percent of the alkaloid composition of the product;</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(2)    Contains synthetic mitragynine, synthetic 7-hydroxymitragynine, or any other synthetic alkaloid or synthetically derived compound from the Mitragyna speciosa plant;</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(3)    Contains a poisonous or otherwise deleterious non-kratom substance, including any substance designated as a controlled substance by this chapter;</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(4)    Is mixed or packed with a non-kratom substance that affects the quality or strength of the kratom product, rendering the product injurious to a customer;</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(5)    Does not include on its package or label the recommended serving size of the kratom product, a recommended number of servings that can be safely consumed in a twenty-four-hour period, and a list of servings per container;</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(6)    Does not include on its package or label the amount of mitragynine and 7-hydroxymitragynine contained in the kratom product; or</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31StatuteNumber1"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">(7)    Does not include on its package or label the following warning statement: "Consult a licensed, qualified healthcare professional before consuming this product. Not for use by women who are pregnant, nursing, or trying to become pregnant."</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31Statute"><span class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont">A violation of this section is a Class 2 misdemeanor.</span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31Normal"><span xml:space="preserve" class="s30ad461e44ec40cd81b29b8f0abadf31000000"> </span></p><p dir="ltr" class="s30ad461e44ec40cd81b29b8f0abadf31NoIndent"><span xml:space="preserve" class="s30ad461e44ec40cd81b29b8f0abadf31DefaultParagraphFont-000001">Source: </span><span class="s30ad461e44ec40cd81b29b8f0abadf31SCL">SL 2025, ch 138, § 3.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s2084769Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084769SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2084769CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s2084769Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084769DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2084769StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } p.s2084769StatuteNumber1-000000 { margin-left: 0.25in; text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084769000001 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s2084769NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s2084769DefaultParagraphFont-000002 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s2084769SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-116 - State directed opioid trust fund established--Source of funds--Purpose."><meta property="og:description" content="SDLRC Codified Law 34-20B-116 - State directed opioid trust fund established--Source of funds--Purpose."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes?Statute=34-20B-116"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s2084769Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-116" rel="noopener"><span class="s2084769SENU">34-20B-116</span></a><span xml:space="preserve" class="s2084769SENU">. </span><span class="s2084769CL">State directed opioid trust fund established--Source of funds--Purpose.</span></p><p dir="ltr" class="s2084769Statute"><span class="s2084769DefaultParagraphFont">The opioid abatement and remediation fund is established in the state treasury. Money received from the following sources may be deposited into the fund:</span></p><p dir="ltr" class="s2084769StatuteNumber1"><span class="s2084769DefaultParagraphFont">(1)    Money received by the state pursuant to settlements or judgments relating to opioids;</span></p><p dir="ltr" class="s2084769StatuteNumber1"><span class="s2084769DefaultParagraphFont">(2)    Any gifts, bequests, or donations; and</span></p><p dir="ltr" class="s2084769StatuteNumber1"><span class="s2084769DefaultParagraphFont">(3)    Interest earned on money in the fund established under this section shall be credited to the fund.</span></p><p dir="ltr" class="s2084769StatuteNumber1-000000"><span class="s2084769DefaultParagraphFont">All money in the opioid abatement and remediation fund may only be used for purposes relating to opioid abuse treatment, prevention, and recovery programs and must be appropriated through the normal budget process. Expenditures of the state from the fund must be assigned to the Department of Social Services.</span></p><p dir="ltr" class="s2084769Normal"><span xml:space="preserve" class="s2084769000001"> </span></p><p dir="ltr" class="s2084769NoIndent"><span xml:space="preserve" class="s2084769DefaultParagraphFont-000002">Source: </span><span class="s2084769SCL">SL 2022, ch 110, § 1, eff. Mar. 18, 2022.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.sfb48639aebc544e497bf28c36916072bNormal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sfb48639aebc544e497bf28c36916072bSENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sfb48639aebc544e497bf28c36916072bCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.sfb48639aebc544e497bf28c36916072bStatute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sfb48639aebc544e497bf28c36916072bDefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sfb48639aebc544e497bf28c36916072bStatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.sfb48639aebc544e497bf28c36916072b000000 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sfb48639aebc544e497bf28c36916072bNoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sfb48639aebc544e497bf28c36916072bDefaultParagraphFont-000001 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sfb48639aebc544e497bf28c36916072bSCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD - Delta-8 Tetrahydrocannabinol, THC-O Acetate, Hexahydrocannabinol--Under Age--Misdemeanor."><meta property="og:description" content="SDLRC Codified Law - Delta-8 Tetrahydrocannabinol, THC-O Acetate, Hexahydrocannabinol--Under Age--Misdemeanor."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes?Statute="><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bNormal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-117" rel="noopener"><span class="sfb48639aebc544e497bf28c36916072bSENU">34-20B-117</span></a><span xml:space="preserve" class="sfb48639aebc544e497bf28c36916072bSENU">. </span><span class="sfb48639aebc544e497bf28c36916072bCL">Delta-8 Tetrahydrocannabinol, THC-O Acetate, Hexahydrocannabinol--Under Age--Misdemeanor.</span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bStatute"><span class="sfb48639aebc544e497bf28c36916072bDefaultParagraphFont">The following actions are unlawful:</span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bStatuteNumber1"><span class="sfb48639aebc544e497bf28c36916072bDefaultParagraphFont">(1)    To knowingly sell or distribute a product intended for human consumption containing delta-8 tetrahydrocannabinol, THC-O acetate, or hexahydrocannabinol to a person under the age of twenty-one;</span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bStatuteNumber1"><span class="sfb48639aebc544e497bf28c36916072bDefaultParagraphFont">(2)    The purchase or attempt to purchase, the receipt or attempt to receive, the possession, or the consumption of, a product intended for human consumption containing delta-8 tetrahydrocannabinol, THC-O acetate, or hexahydrocannabinol to a person under the age of twenty-one; and</span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bStatuteNumber1"><span class="sfb48639aebc544e497bf28c36916072bDefaultParagraphFont">(3)    To purchase a product intended for human consumption containing delta-8 tetrahydrocannabinol, THC-O acetate, or hexahydrocannabinol on behalf of, or to give a product intended for human consumption containing delta-8 tetrahydrocannabinol, THC-O acetate, or hexahydrocannabinol to, any person under the age of twenty-one, unless the purchaser is a parent or guardian of the person under the age of twenty-one.</span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bStatuteNumber1"><span class="sfb48639aebc544e497bf28c36916072bDefaultParagraphFont">A violation of this section is a Class 2 misdemeanor.</span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bNormal"><span xml:space="preserve" class="sfb48639aebc544e497bf28c36916072b000000"> </span></p><p dir="ltr" class="sfb48639aebc544e497bf28c36916072bNoIndent"><span xml:space="preserve" class="sfb48639aebc544e497bf28c36916072bDefaultParagraphFont-000001">Source: </span><span class="sfb48639aebc544e497bf28c36916072bSCL">SL 2022, ch 111, § 1.</span></p></div></body></html><br /><hr><br /><html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 34-20B - DRUGS AND SUBSTANCES CONTROL</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.s080f4de79cc54609bdccbb9454ae12c8Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s080f4de79cc54609bdccbb9454ae12c8SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s080f4de79cc54609bdccbb9454ae12c8CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.s080f4de79cc54609bdccbb9454ae12c8Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s080f4de79cc54609bdccbb9454ae12c8StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.s080f4de79cc54609bdccbb9454ae12c8000000 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.s080f4de79cc54609bdccbb9454ae12c8NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont-000001 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.s080f4de79cc54609bdccbb9454ae12c8SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } body { text-decoration-skip-ink: none; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 34-20B-118 - Industrial hemp--Chemical modification or conversion--Sale or distribution--Penalty."><meta property="og:description" content="SDLRC Codified Law 34-20B-118 - Industrial hemp--Chemical modification or conversion--Sale or distribution--Penalty."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/34-20B-118"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8Normal"><a href="https://sdlegislature.gov/Statutes?Statute=34-20B-118" rel="noopener"><span class="s080f4de79cc54609bdccbb9454ae12c8SENU">34-20B-118</span></a><span xml:space="preserve" class="s080f4de79cc54609bdccbb9454ae12c8SENU">. </span><span class="s080f4de79cc54609bdccbb9454ae12c8CL">Industrial hemp--Chemical modification or conversion--Sale or distribution--Penalty.</span></p><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8Statute"><span class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont">No person or entity may:</span></p><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8StatuteNumber1"><span xml:space="preserve" class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont">(1)    Chemically modify or convert industrial hemp as defined in § </span><a href="https://sdlegislature.gov/Statutes?Statute=38-35-1" rel="noopener"><span class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont">38-35-1</span></a><span class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont">, or engage in any process that converts cannabidiol, into delta-8 tetrahydrocannabinol, delta-9 tetrahydrocannabinol, delta-10 tetrahydrocannabinol, or any other tetrahydrocannabinol isomer, analog, or derivative; or</span></p><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8StatuteNumber1"><span class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont">(2)    Sell or distribute industrial hemp or an industrial hemp product that contains chemically derived cannabinoids or cannabinoids created by chemically modifying or converting a hemp extract.</span></p><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8Statute"><span class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont">A violation of this section is a Class 2 misdemeanor.</span></p><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8Normal"><span xml:space="preserve" class="s080f4de79cc54609bdccbb9454ae12c8000000"> </span></p><p dir="ltr" class="s080f4de79cc54609bdccbb9454ae12c8NoIndent"><span xml:space="preserve" class="s080f4de79cc54609bdccbb9454ae12c8DefaultParagraphFont-000001">Source: </span><span class="s080f4de79cc54609bdccbb9454ae12c8SCL">SL 2024, ch 129, § 2.</span></p></div></body></html>